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ABSTRACT

This study was to determine if rats infected with Trichinella spiralis muscle
larvae would show a rapid proliferation of antibody (Ab)-expressing B cells in the non-

Peyer’s patch region of the small intestine, and if these B cells when compared to the
overall B cell count were secreting multiple isotypes of Ab. AO rats were infected with

'Trichinella spiralis muscle larvae and tissues of the small intestine, Peyer’s patch (PP),
mesenteric lymph node (MLN), and spleen were obtained on days 1, 3, 5, 7, 10, and 15

after infection (including the uninfected controls). The tissues were cryo-histologically

processed, and stained with.either a pan B cell marker (0X33) conjugated with
rhodamine (XRIT.C) or combinations of dual monoclonal Ab probes plus secondary Ab

conjugated with XRITC or fluorescein (FITC). As compared to the uninfected controls
(day 0), a significant increase in the number of dual Ab-expressing B cells (Debc) in the

non-Peyer’s patch tissues of the small intestine was observed as early as day 3 with a
maximum proliferation on days 7 and 10. B cells were also activated in the lymph
tissues, but with delayed kinetics. In the MLN and the spleen, significant proliferation of

Debc occurred on days 7 and 10 respectively. The non-germinal center regions of the

Peyer’s patch (PP-NGC) showed little proliferation throughout, but a significant number
of Debc was found as of day 10 over the controls. Within the PP-germinal centers (PP-

GC) there were a relatively high number of Debc and single Ab-expressing B cells (Sebe)

in the controls compared to the other tissues. As infection took place, a significant
proliferation of Debc occurred on day 3. By adding all of the numbers of Debc

combinations within each tissue for each of the respective days, and comparing those
iii

numbers with the total quantified number of B cells, it showed that the Debc were most

likely expressing more than two isotypes on the surface during the peak days of
proliferation. In the small intestine, the combined numbers of Debc were > 7 times that

of the total number of 0X33 labeled B cells on day 7. In the lymphoid tissues, a similar

pattern was seen. The PP-GC Debc were > 5 times higher than 0X33 labeled B cells on
day 15, the spleen Debc were > 6 times higher than 0X33 labeled B cells on day 10, and
the MLN Debc were > 3 time higher than 0X33 labeled B cells on day 10. In the PP-

NGC no multiple expression was detected. The significance of this study was to show
first that Ab-expressing B cells are proliferating in the non-Peyer’s patch region of the

small intestine early on during infection with Trichinella spiralis, as compared to the
surrounding lymphoid tissues. Secondly, it demonstrated that these activated B cells

were expressing two different Ab isotypes on the surface with the possibility of multiple

isotype expression.
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1) Introduction

1.1 Introduction to the Immune System:
Immune responses in the body are designed to recognize and distinguish between
“self’ and “non-self’. It is therefore specialized not to disable cells, proteins, etc. that are
normally found within the body, but to become activated against environmental agents

that would be considered foreign to the body. Foreign agents could be organisms such as
bacteria, viruses, and parasites that contain antigens (Ag) which trigger host immune

responses. Cells of the immune system are only found in vertebrates, and develop from
pluripotential stem cells in the bone marrow, fetal liver, and fetal spleen tissue as

reviewed by Benjamini et al. (1996). These cells are separated into five general classes
of white blood cells (WBC) being either specific or nonspecific against any potential Ag.

WBC are located throughout the body in nearly all organs and tissues, including
brain, liver, and skin. Some tissues, under normal physiological conditions, have higher
numbers of WBC such as the spleen, bone marrow, thymus, and various lymph tissues.

WBC consist of neutrophils, basophils (mast cells in the tissues), eosinophils, monocytes

[macrophages (M<()) in the tissues], and lymphocytes (B cells, T cells, and null cells).
Neutrophils, basophils, and eosinophils are referred to as polymorphonuclear (PMN)
granulocytes because of the multi-lobed nucleus and the large number of intracellular

granules that contain many hydrolytic enzymes that are released toward the invading

organism when the PMN cells become activated. Neutrophils are generally short-lived,
nonspecific, and phagocytic cells that engulf an organism that it contacts. Phagocytosis

in eosinophils is very uncommon, and in basophils is non-existent. PMN have the ability
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to interact with an organism that has bourid antibodies (Ab). On a cell surface, the Ab

produced by B cells can then bind to Fc receptors (FcR) on PMN cells. Among the most

common FcR in PMN cells are FcyR (Ravetch et al., 1991; Unkeless et al., 1988) specific
for IgG Ab, and FcsR (Takizawa et al., 1992; Shaikh et al., 1997) specific for IgE Ab.

Once the PMN binds to the cell-bound Ab, degranulation occurs. These granules then

attack cells nonspecifically and cause a leaking out of intracellular components, and cell
death. Unlike M<|), PMN cells are short lived, and do not usually act in Ag-presentation
to T cells. Gosselin et al. (1993) though did suggest using an in vitro human cell line,
that neutrophils could be induced to express MHC class II molecules and could therefore

play a significant role in immunoregulation and pathogenesis of disease. This type of
study has yet to be shown though during an in vivo response.

M(J) are similar to PMN cells by being phagocytic and nonspecific as to the

organism it engulfs. M<(),are specialized for phagocytizing foreign agents, foreign cells,
particulate material, and/or dying cells that are present in the body. These are

mononuclear cells that are considered long lived when compared.to PMN life spans of 1
to 2 days (Bainton et al., 1971). This longer life span allows for.the differentiation of

monocytes in different tissues. Some of these include Kupffer cells in the liver (Naito et
al., 1997), osteoclasts in bone (Quinn et al., 1996), alveolar cells in the lungs (Higashi et
al., 1992), and dendritic cells in the spleen and other lymph tissues.
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M<|) can use FcyR on its surface to bind to IgG, that have specifically bound to an
Ag (ex. foreign cells) (Ravetch, 1991). M(|) also have the capability of expressing
complement (C’) receptors on its surface which can bind C’-coated particles and lead to

eventual phagocytosis, a process known as opsonization.
The invading organism that comes into contact with the M<j) is phagocytized,
becoming encased in a vesicle called a phagosome, that undergoes a fusion with

lysosomes. The lysosomal enzymes then break down the organism into small particles.

These particles (i.e. Ag) can be expressed along with the major histocompatibility
complex (MHC) class I and class II molecules on the surface of the M<j). Once the M(j) is

activated, it is able to secrete cytokines like interleukin-1 (IL-1) (Hilbi et al., 1997), IL-6
(Ghaffar et al., 1998), IL-12 (Muller et al., 1997), and tumor necrosis factor a (TNFa)
(MacDermott, 1996). Some of these cytokines then lead to activation of T cells and B

cells that make up the specific immune defense.

T cells make up the cell-mediated immunity and consist of several major cell

types including CD4 + T helper cells (Th), CD4+ delayed type hypersensitivity (Tdth)
cells, and CD8+ T cytotoxic cells (CTL). After being produced in the bone marrow, the T
cells migrate to the thymus to become fully differentiated. Mature T cells migrate to the

peripheral lymphoid tissues and are able to respond to Ag. To become activated, an Ag

must be presented to the T cell in association with the MHC molecule. MHC molecules
consist of two types, class I MHC, and class II MHC. Class I MHC molecules are
expressed on virtually all cell types where as class II MHC molecules are limited to only
a few cell types including B cells, T cells, and M<j) (Sprent, 1993). T cells express T cell
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receptors (TcR) that recognize and bind to MHC molecule only when processed Ag is

being presented with the MHC molecule on the surface of the cell. Upon TcR-Ag-MHC
binding, either CD4 or CD8 molecules of T cells will extend out and bind to a

nonpolymorphic site on the MHC molecule to strengthen the interaction (Sprent, 1991).
Using CD3, a signal transduction molecule closely associated with the TcR, a signal

enters the T cell and leads to T cell activation (Hedrick et al., 1993).

CD8+ cytotoxic T lymphocytes (CTL) bind specifically to processed Ag presented
by MHC class I molecule, and when activated they bring about cytolysis and cell death of

the “target” (von Boehmer, 1988). Specific targets of these killer lymphocytes are
principally host cells infected with intracellular microorganisms such as viruses, certain

bacteria, and some cancerous cells (Berke, 1997). CTL act mainly under the control of
CD4 T helper cells and the cytokines these cells produce. A CTL is activated by 1) TcR-

Ag-MHC II complex, 2) CD28-B7 interaction, and 3) the CD4 T helper cells which then
secrete IL-2, IL-12, and ylFN among others. The CTL will then differentiate, proliferate,

produce memory cells, and cause lysis of the target cell.

CD4+ helper T cells act as the major regulatory cells of the immune system.

These cells recognize processed Ag presented by MHC class II molecule via the TcR,
and are specialized to react with Ag derived from extracellular sources (Fitch et al.,

1993). When CD4 cells become activated, cytokines are secreted to allow for a wide
variety of immune responses. CD4 T helper cells are generally broken into two subsets,
T helper 1 (Thl) and T helper'2 (Th2), depending on their functional capabilities and
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cytokines they produce. The Thl subset secretes cytokines such as ylFN, TNF, and IL-2,
which are usually associated with inflammation, and cell-mediated immune responses

(Constant et al., 1997). The Th2 subset produces cytokines such as IL-4 and IL-5 that

help B cells to proliferate and differentiate and is associated with humoral-immunity
(Constant et al., 1997).

1.2 B Cells and Antibodies:
B cells are a central part of the humoral immune response that includes
production of antibody (Ab) to interact with a specific epitope on an Ag. B cells express

MHC class I and class II molecules on the surface so they maintain the capability of
being an Ag-presenting cell (APC), to T cells. The main function of B cells is to produce

and secrete Ab.

Ab, also known as immunoglobulins (Ig), are glycosylated proteins that function
1) to neutralize an Ag, 2) opsonization, 3) antibody-dependent cell cytotoxicity (ADCC),

and 4) C’ activation. The basic structure of an Ab includes two identical heavy chains
and two identical light chains held together by disulfide bonds. An Ab can be

enzymatically cleaved into two main fragments of these four polypeptide chains, the Fab
and the Fc fragments. The Fab fragments are responsible for Ag binding. TheFc
fragments function in binding to phagocytic cells via the FcR, activation of C’, and also

can mediate other biological activities.

5

Each chain (both heavy and light) has two regions, the constant and the variable.

Within the variable region are several hypervariable regions that actually form the

binding site for an Ag. It is this variability of sequences of amino acids that provides the
diversity in the Ag binding site. Connected to the variable region is the constant region
on both the heavy and light chains. The constant region of the heavy chain is important
in determining the biological function of different Ab and their isotypes. Ab isotypes

consist of IgM, IgD, IgA, IgG, and IgE, which allow for response to various types of
pathogens.
During B cell development, IgM and IgD are found first on the B cell surface.
Little is known about the function of IgD, either membrane-bound or in the serum.
However, what is known is that it is present in low quantities and has a short half-life.

IgM is the first Ab produced in primary immune responses, which leads to activation of

naive B cells. IgM is also a surface marker for both immature and mature B cells
(Carayannopoulos et al., 1993). When secreted into the serum, IgM becomes a pentamer

that is joined together by a polypeptide called a J chain. When bound to microorganisms,
IgM leads to C’ activation (Wright et al., 1990) and thus Ag destruction.
IgG is the most well studied isotype and is the predominant immunoglobulin in

the blood, and lymph fluid making up to 70-75% of Ab molecules produced in the serum.
There are generally four subclasses designated IgGl, IgG2, IgG3, IgG4 in humans; IgGl,

IgG2a, IgG2b, IgG3 in mice; IgGl, IgG2a, IgG2b, IgG2c in rats (Snapper et al., 1993).
Although IgG is produced in a primary immune response, it is the major Ab produced in
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secondary immune responses. IgG is produced by memory B cells in a secondary
immune response, which is a much quicker response than primary immune responses.
IgG is also important in Ag neutralization, ADCC, and also C’ activation.

The final two isotypes are IgA that is expressed mainly in mucosal sites, and IgE
that is important in parasitic infections and allergic reactions. IgA is present mostly as a
dimer with a primary function against local infections in the intestine, respiratory tract,

and other mucosal tissues. IgA is also produced in the highest amount in the body with .

5-15g being secreted in mucous per day as reviewed by Kuby (1997). There is usually

more IgA-producing B cells within the intestine than total Ab-producing B cells in the
spleen, lymph nodes, and bone itiarrow combined (Lamm, 1997). Under normal
circumstances, IgE is present in the serum at the lowest concentration of all Ab isotypes,

and it is important for protection against certain microorganisms and is also involved in
certain allergic responses. IgE binds with high affinity to the FcsR on mast cells,

basophils, and with low affinity to eosinophils, to lead to degranulation and an
inflammatory response.

B cells originate in the bone marrow from progenitor hemopoietic stem cells that

lead to the production of pro-B cells arid the beginning of Ab gene rearrangement. The
production of Ig components plays an important signaling role in guiding the initial
stages of B cell differentiation (Tough et al., 1995). From pro-B cells to pre-B cells

arrangement of the heavy chain is completed with the expression of a CM (leads to IgM
heavy chain expression). DNA recombination of a diversity (D) gene with a joining (J)

segment starts this process. The D region is then linked to a variable (V) gene, and
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finally the J segment binds to the constant (C) region gene that contains the genes to
express all of the possible isotypes. There are about 100 possibilities for V, 50 for D, and
6 for J genes for each human Ab. The random rearrangement is one of the reasons for

such diversity among Ab specificity toward an Ag. Once the heavy chain gene

rearrangement takes place, specific B cell lines can only produce immunoglobulins of

one antigenic specificity. The next step in development is that from pre-B cell to
immature B cell, and this is the point where the light chains are produced. IgM is then
expressed on the surface of the B cell. Light chains do not have a D segment, and the C

segment is limited to either A, or k. After successful rearrangement of one of the light
chain genes, the B cell is considered mature, expressing both IgM and IgD on the surface,
and awaiting to be activated by a specific Ag.

B cell activation by an Ag proceeds in two possible routes, a T cell dependent
(TD) pathway or a T cell independent (TI) pathway. Activation by TD Ag involves a

complex interaction between B cells and Th cells. The surface Ab of a B cell first binds
to the Ag and the B cell then internalizes the Ab-Ag complex and processes the Ag for
MHC II expression. TcR are now able to link to the processed Ag on the MHC II
because the B cell is now acting as an APC. A CD40 molecule on the B cell also binds to

a CD40L on the T cell, which in turn stimulates expression of cytokine receptors on the B
cell. This interaction between CD40 and CD40L is necessary for the initiation of the last

phase of B cell development (Klein et al., 1997). This last phase includes the production
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of plasma cells for Ab secretion, isotype switching, and production of memory cells for a

more rapid secondary response to the specific Ag in the future. In this process, M<j) can
also act as APC. Together with Th cells, they can activate B cells specific for a TD Ag.

B cells can respond to Ag without the help of Th cells though only few B cells use

this pathway. Examples of TI Ag are lipopolysaccharides (LPS) and other

polysaccharides that have multiple repeating units that are often found on bacterial cell
walls. These Ag cause cross-linking of surface Ab on a B cell and therefore mobilize Ab

toward one specific region on the B cell membrane. This process is referred to as
“patching” and “capping”. The B cell internalizes the Ab-Ag complex via receptor-

mediated endocytosis, becomes activated, and leads to proliferation and Ig secretion. B
cells activated in this manner typically produce only IgM, and they do not give rise to
memory cells. This means that a TI reaction will always give a primary response to its

specific Ag, where as the TD response can produce memory cells for a much more rapid

secondary response to a particular Ag.
Once activated, B cells have the capability of undergoing a process called isotype

switching. Isotype switching allows for the Ab to keep its specificity while generating a

more extensive immune response. A general model for this process involves a further
rearrangement of the heavy chain DNA in which the VD J unit can combine with any C

gene segment (Chen et al., 1993). Between each C segment there is a region referred to
as a switch site (S), which allows the DNA strand to loop around and connect to the SM
site. All C segments between the Cg and the selected C segment are then excised out of
the DNA strand and the new isotype is expressed. Because of the DNA recombination
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and deletion, the B cell’s genome will no longer contain the deleted C segments and

therefore are no longer able to express other isotypes of Ab. An alternative approach to
isotype switching involves a similar process, but differential RNA splicing occurs after

transcription (within the RNA strand). This RNA splicing process allows the B cell to
maintain its entire C region at the DNA level. Therefore the B cells are still able to

express other Ab iso types through production of new RNA strands. It is important to

note that because Ab specificity is determined by the variable region of Ab, class

switching does not change the Ag-binding specificity (Stavnezer, 1996).
Isotype switching is commonly stimulated by various cytokines that are produced
by T cells. Th cells produce the cytokines that help activate the B cells. Some cytokines

such as IL-4 stimulates production of IgG and IgE, IFN-y stimulates increased levels of
IgG2a and IgG3, and TGF-(3 stimulates increased levels of IgG2b and IgA (Morawetz et
al., 1996).

1.3 Mucosal Immunity and the Intestine:

The linings of the mucosal tissues have the largest surface area of any part of the

body (Mowat et al., 1997). Mucosal tissues include the gastrointestinal (GI) tract, upper
and lower respiratory tracts, urogenital tract, and oral cavity. Mucosal tissues consist of

the outer epithelium and the inner connective tissue lamina propria. Mucosal epithelium

of the GI tract contains columnar absorptive cells, Paneth cells, goblet cells, tuft cells,
cup cells, enteroendocrine cells, undifferentiated crypt epithelial cells, and intraepithelial

lymphocytes, all of which are important for absorption of nutrients and/or protection of
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the GI mucosa. Within the lamina propria there are various immunocompetent cells

including M<)>, dendritic cells, and lymphocytes that help to prevent the further entrance

of pathogens into the body.
The cells lining the mucosa are constantly being exposed to pathogens, including

viruses, bacteria, and multi-cellular parasites. Thus, it is due to this constant
bombardment of pathogens that vertebrates developed a mucosal immune system. This

developed host defense includes barriers against potential pathogens such as GI acidity, a
thick mucous membrane, and the various cells involved in immune responses. The cells

of the mucosal immune system work the same way as those in other non-mucosal tissues,

except that most immunity tends to be localized within mucosal tissues rather than

systemic. APC, including B cells, M<(), dendritic cells, and epithelial cells (Kaiserlian et
al., 1989) process Ag, express the processed Ag on MHC II, and activate Th cells.
Activation of TIB cell and CTL cells does occur, although in much lower frequencies.

Activation of the Th cells locally lead to activation and proliferation of B cells,

which produce mucosal responses to pathogens. IgA, produced and secreted by B cells,
are the major Ab produced in mucosal secretions (Klein et al., 1997; Ogra et al., 1994).

After secretions of IgA from the B cells, IgA becomes dimeric by acquiring a J chain and

a secretory component (SC) as it passes through mucosal epithelial cells into the lumen.
Once in the lumen, SIgA binds and neutralizes potential pathogens before they enter the

body through the mucosal tissues. Although IgA is the major Ab found in mucosal

regions, other classes of Ab, such as IgM, IgG, and IgE, can also be present in mucosal

tissues, depending on the infectious pathogen (Lamm, 1997; Mestecky et al., 1999).
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Among the best-studied mucosal immune tissues are the gut associated lymphoid

tissues (GALT) of the GI tract. GALT comprises the Peyer’s patch (PP), mesenteric
lymph nodes (MLN), and a large number of lymphocytes throughout the lamina propria
and epithelium of the intestine (Mowat et al., 1997). One of the major functions of

GALT is the elaboration of B cells and in particular IgA-producing B cells, which have

been well studied within this region (Kawanishi et al., 1983a; McIntyre and Strober,
1999).
PP is a secondary lymphoid tissue that is located in the submucosal lining of the

intestine. Within the PP are regions called germinal centers, from which B-lymphocytes
are able to mature into plasma cells and undergo class-switching from IgM to IgA and

also other Ab classes like IgG (Weinstein and Cebra, 1991). The non-PP regions of the

intestine where lymphocytes reside are structured as villus crypt units (VCU), which
consist of the epithelium and lamina propria tissues. Within this tissue are also several

different cells of the immune system such as B cells, T cells, and dendritic cells. A major
feature of the B cells are that most have already differentiated into plasma cells and are

therefore instantly available for response to infection. Draining the lymph from these two
areas of the intestine is the MLN that harbors lymphocytes and M<(>, which can further
drain into the blood stream for systemic circulation. This would allow protection for the

rest of the body to potential pathogens that may infect elsewhere.
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1.4 Life Cycle of Trichinella spiralis'.
A well-known parasite Trichinella spiralis is able to infect the epithelial layer of
t

the intestine in all mammals. As dogs, swine, rodents, or humans ingest meat infected

with Trichinella spiralis, the Trichinella spiralis muscle larvae (ML) are able to survive

and infect its new host (Hickman et al., 1984). Ingested ML enter the intestinal

epithelium and undergo four molts to become adult worms (Pond et al., 1989). Here the
adult worms mate and produce newborn larvae (NBL) that migrate through the lymph
nodes and into the bloodstream and lymph. These NBL will eventually reach muscle

tissues where they will bury in coiled position and form cysts (Ritterson, 1966; Wang et
al., 1987). Trichinella spiralis now encysted within the muscle tissue can reside there for

the life of the host or if ingested result in infection of a new mammal.

1.5 Purpose of This Study:
Intestinal immune responses have been well characterized against various

infectious parasites such as Nippostrongylus brasiliensis (el-Hag et al., 1989), Trichuris
muris (Grencis, 1993), Trichinella pseudospiralis (Wakelin et al., 1994), and Trichinella
spiralis (Wakelin et al., 1994; Ishikawa et al., 1997). Infection with Trichinella spiralis
muscle larvae has been extensively studied due to its specific infection within the
epithelial layer of the small intestine. This infection leads to active immune responses by

both T cells and B cells that can lead to the eventual expulsion of the pathogen. Most B
cell research involving intestinal pathogens has revolved around IgA production in the

Peyer’s patches (Spencer et al., 1986; Jeska et al., 1989); Trichinella spiralis research is,
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only recently, turning to other nonlymphoid intestinal regions and investigating the

possibility of other isotypes of Ab being produced. T cell responses to intestinal
helminthic infections are primarily Th cells, and specifically from Th2 (Grencis, 1997;

Ishikawa et al., 1997; Wang et al., 1990).

Wang et al. (1990) showed that 0X22' (Th2) T cells led to eosinopoiesis against
Trichinella spiralis in the intestine, and there was a rapid proliferation of Th2 cells within

12hrs of Trichinella spiralis infection. The fact that Th2 cells produce cytokines like IL4 and IL-5 would suggest a wider range of isotypes of Ab (other than IgA) being
produced by B cells against this pathogen. This is due to IL-4 being responsible for the
production of IgE, among other Ab isotypes, while IL-5 enhances eosinophilia (Hamada
et al., 1992). Previous studies have shown that Trichinella spiralis infected rats transport

IgE from the plasma to intestinal tissue (Negrao-Correa et al., 1996). Wang et al. (1998)
have shown elevated production of all major Ab isotypes by B cells, and more recently

(Wang et al., 1999) a particularly high increase in IgE and IgGl in the intestine of rats
infected with Trichinella spiralis.
There are five Ab isotypes and in principle, the higher diversity of isotypes of Ab
secreted by B cells will result in a stronger and broader spectrum of protection that is
generated in the host. The results produced from Wang et al. (1998, and 1999) showed

the possibility that B cells may be capable of producing more than one Ab isotype on its

surface at a given time towards the Trichinella spiralis Ag. This observation is based on
the overwhelming number of Ab-producing B cells counted per villus crypt unit in this

study, and also because all of the Ab isotypes were found to be expressed by B cells
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throughout. Few studies have dealt with the possibility of multiple isotype expression by

B cells (Fujieda et al., 1996; Shimizu et al., 1991; Goodman et al., 1997; Nolan-Willard
et al., 1992), and none of these studies were reproduced in vivo. Rather most studies

involving the production of multiple Ab isotypes by B cells have been in vitro, using

various cell lines. Most investigations of an immune response by B cells producing
multiple Ab isOtypes were in lymphoid tissue as well, and involved limited variations
within the different isotypes being expressed. The experiments described in this thesis

were designed to determine first whether there was rapid proliferation of Ab-producing B
cells in the nOn-Peyer’s patch region of the small intestine in rats infected with

Trichinella spiralis muscle larvae. Secondly, the study examined whether these B cells
expressed multiple isotypes of Ab at a given time. The isotypes of each specific Ab

isotype for IgA, IgM, IgGa, IgG2a, IgG2b, and IgG2c was identified by a fluorescent
marker (fluorescein), and then B cells were viewed using a second fluorescent marker

(rhodamine) specific for IgE to determine if multiple Ab were expressed. Following this
procedure the total number of B cells were quantified using a pan B cell marker, 0X33

monoclonal Ab, that labels CD45RA found only on B cells in rats (PharMingen, 1998).
This CD45 isoform is found on all pre-B cells, immature, mature, and activated B cells.

B cells expressing various Ab isotypes were examined in Peyer’s patches for germinal

center and non-germinal center regions, mesenteric lymph node, spleen, and a

nonlymphoid region of the small intestine. The data obtained from these experiments are
presented in this thesis and they demonstrate that intestinal B cells are indeed activated

rapidly during the early stage of infection with Trichinella spiralis. Moreover, these B
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cells are able to produce at least two, and most likely more than two, Ab isotypes upon

activation. This study is the first of its kind to provide definite evidence of co-expression
of multiple Ab isotypes by activated B cells in the gut-associated lymphoid tissues
against a parasitic pathogen during an early stage of a natural infection.
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2) Materials and Methods
2.1 Experimental Animals:

Male or female pathogen-free AO rats of six to eight weeks of age were
randomized into seven groups of six to conduct this experiment. Rats were purchased
from Harlan-Sprague Dawley (Indianapolis, In), and maintained at the California State

University San Bernardino vivarium where food and water were distributed ad libitum.

2.2 Infection with Trichinella spiralis Muscle Larvae:
Muscle larvae from infected rats were isolated by digesting minced rat carcasses

with 1% pepsin hydrochloride at 37 °C for 1 hr. The digested fluid was first filtered
through cheesecloth to remove bones and undigested tissues, and then filtered through a

200 - mesh sieve using 0.85% NaCl to retain the larvae. Muscle larvae were then
counted and the concentration adjusted accordingly. Infection was carried out by

injecting 2,000 muscle larvae per rat orally using a blunt end feeding needle.

2.3 Processing of Tissues:
Tissues from the small intestine (15 cm distal from the pylorus), Peyer’s patch

(nearest to the portion taken from the intestine), mesenteric lymph node, and spleen were
obtained from both control (day 0) and infected rats. Tissues of rats infected with the
Trichinella spiralis muscle larvae were collected on days 1, 3, 5, 7, 10, and 15. Tissues

were cryo-histologically processed using a snap-freezing technique (Lincoln et al., 1998).
Described briefly, tissues were immersed in isopentane (cooled in liquid nitrogen) for 10
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sec, and then added along with Histo Prep tissue embedding media (Fisher Scientific,

Pittsburg, Pa:) to an aluminum foil cup. Tissue were then frozen and stored at - 80 °C
until further processing. Each of the frozen tissues was cut into 6pm sections using a Lab

Tek Precision Microtome Cryostat (Lab Tek Instruments Co., Westmont, IL.). The tissue

sections were then placed on slides coated with Poly-L-lysine, and allowed to air diy.
Slides were then fixed in 2% paraformaldehyde at room temperature for 20 min, and

finally washed three times in IX PBS pH 7.2 (5 min each wash).

2.4 Immunofluorescence Staining:

A double-labeling immunofluorescence assay was used in order to show the

different isotypes of antibodies expressed by B cells located within the tissues. All
antibody probes were purchased from Accurate Chemicals and Scientific Corp.

(Westbury, NY.), or Zymed Labs Inc. (San Francisco, CA). The optimal dilution of each
of the antibody probes has been previously determined (Wang et al., 1998). Each tissue
section was stained for 1 hr at room temperature with 20 pL per section of 1:500 diluted

monoclonal mouse anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, or IgG2c, respectively.
Following incubation, this primary antibody was aspirated off, and slides washed three

times in IX PBS pH 7.2 for 5 min. Then 20 pL of fluorescein isothiocyanate (FITC)

conjugated goat anti-mouse Ig [F(ab)2’], and goat anti-rat IgE labeled with rhodamine
isothiocyanate (XRITC) [F(ab)25] were added to each slide in a 1:1000 dilution and

mixed together in a 1:1 ratio. These Ab were H chain specific and in the F(ab)2’ form to
prevent non-specific binding to the Fc receptors. Normal rat serum was used at a dilution
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of 0.1 % in the antibody preparation to prevent non-specific binding. FITC conjugated

antibody stained the mouse antibody isotypes green, and the XRITC conjugated antibody

specifically shows a red color when bound to IgE producing B cells. This fluorescence
staining was taken under dark conditions at room temperature for 1 hr. Slides were once

again washed three times in IX PBS pH 7.2 for 5 min. Each slide was then mounted with
fluorosave to prolong the staining effect, and then coverslips added. Antibody labeled B

cells were viewed using a Nikon Optiphot Biological Microscope with an Episcopic-

Fluorescence attachment EF-D containing a B2A 495nm filter specific for viewing FITC,
and a G2A 546nm filter specific for viewing XRITC. Single and double-labeled cells of
at least 10-20 villus crypt units (VCU) per intestine and 10-20 fields (400X) per section
for spleen, Peyer’s patch, and mesenteric lymph node were counted visually for each rat.

2.5 0X33 Staining:
0X33 is a monoclonal antibody that identifies a pan-B cell marker, CD45, on rat

B cells (0X33 is a gift from Oxford University to Dr. Ching-Hua Wang). This antibody

has been conjugated with XRITC in this laboratory. After staining with this antibody
probe, the overall number of B cells in each of the four tissues in infected versus control

rats, were enumerated. Each tissue section was cut similar to that described above,
placed on the Poly-L-lysine coated slides, fixed with 100% acetone at -20 °C for 2 min,

and washed three times in IX PBS pH 7.2 for 5 min. In order to determine the optimal
staining conditions, several slides were stained with different dilutions of mouse anti-rat
0X33 monoclonal antibody labeled with XRITC for lhr at room temperature to
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determine optimal staining. The 0X33 was then aspirated off and washed three times

with IX PBS pH 7.2 for 5 min. Once an optimal dilution was determined, then slides for
each tissue and day of infection were stained and washed in the same manner. Overall B

cell numbers were counted visually using the fluorescent microscope as described

previously.

2.6 Statistical Analysis:
Data were analyzed using Microsoft Excel 97. Tools used from this program

included a one-factor analysis of variance (ANOVA) for determination of differences in

OX33-labeled B cells, and two-factor ANOVA with replication for determination of
differences between different dual Ab-expressing B cell (Debc) combinations and also

the differences between Debc and the respective single Ab-expressing B cells (Sebc).

Effects that resulted in a significant F value were then subjected to Student-Newman
Keuls multiple range tests for determination of significant differences between groups.

Student-Newman Keuls tests were calculated using equations from Statistical Methods
(Snedecor and Cochran, 1980).
Forty-two rats were infected with Trichinella spiralis on day 0. Six rats were

sacrificed on days 1,3, 5, 7, 10, and 15 post infection. Six uninfected rats were sacrificed
on day 0 to act as controls. On each of the sample days tissues from the small intestine,

spleen, MLN, and PP were obtained from each rat. One slide carrying 3-5 tissue sections
was prepared for each tissue from each rat. Dual and single Ab-expressing B cells form

each of the tissues were counted on each slide, and the means of 20 fields (villi in the

20

small intestine) at 400X magnification were calculated for each rat. The mean value
from the 20 fields (or villi) for each rat was then used to determine the group means of

Ab-expressing B cell proliferation for different combinations of Debc, or between Debc
and Sebc. These values were analyzed using ANOVA.

The day specific means of different dual-Ab expressing B cell combinations were
compared using a two-factor ANOVA with day and dual-Ab combination as fixed
effects. In this analysis a significant day effect would indicate different levels of dual

Ab-expressing B cell proliferation over the course of the infection. A significant dual
Ab-expressing B cell effect would indicate that there were differences in the level of

expression of the different dual Ab-labeled B cell combinations. Effects resulting in
significant F values from the two-way ANOVA were then subjected to a StudentNewman Keuls test to determine any significant differences between cell means. Values
of q with p<0.05 were considered significant.
The day specific means of Debc and Sebc were compared using a two-factor

ANOVA with day and Ab-expression by B cells as fixed effects. The purpose of this

analysis was to determine if there were any differences between Ig_:IgE-Debc, Ig_-Sebc,
and IgE-Sebc within each day of infection. In this analysis a significant day effect would

indicate different levels of Ab-expressing B cell proliferation over the course of the
infection. A significant Ab-expression effect would indicate that there were differences

in the level of expression of the different Ab-expressing B cell combinations. Values
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resulting in significant F values were then subjected to a Student-Newman Keuls test to

determine any significant differences between cell means. Values of q with p<0.05 were

considered significant.
The means of OX33-Ab data were compared using a one-factor ANOVA for each
tissue tested, with day as a fixed effect. The CD45RA+ B cells were labeled with 0X33Ab, and this gave a general idea of the total number of B cells within each tissue for

respective days post infection. The one-factor ANOVA determined if there was a

difference in the total number of CD45RA+ B cells on different days post-infection with
Trichinella spiralis. If the day effect was significant, day means were then subjected to a

Student-Newman Keuls test to determine which days differed. Values of q with p<0.05
were considered significant.
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3) Results

To determine the expression of Ab by B cells, AO rats were infected with 2,000
Trichinella spiralis muscle larvae on day 0 of infection. Rats were randomly assorted
into seven groups of six rats and tissues were taken from the small intestine 15cm distal

to the pylorus, the Peyer’s patches, mesenteric lymph node, and the spleen on days 0
(control), 1, 3, 5, 7, 10, and 15 of infection. Tissues were cryo-histologically processed
and then labeled with monoclonal mouse anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, or

IgG2c Ab respectively, followed by FITC-conjugated goat anti-mouse Ig- and XRITCconjugated goat anti-rat IgE Ab in a 1:1 ratio. The appearance of Ab-expressing B cells

were quantified as either single expressing B cells (Sebc) or dual expressing B cells

(Debc) by immunofluorescence microscopy. B cells expressing IgE appeared bright-red
when using a 546nm filter, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c expressing

B cells appeared bright-green when using the 495nm filter. Figure 1 shows the color
signals that are produced by this fluorescence labeling technique. The photographs are of
samples from the small intestine on day 7, spleen, MLN, PP-NGC, and PP-GC on day 10

of infection. In Figure 1 (A, C, E, G, and I), FITC-labeled IgGl-expressing B cells are

shown to be localized within a field or villus crypt unit (VCU) in the small intestine using
a 495nm filter. In Figure 1 (B, D, F, H, and J), the above B cells that also express IgE are

bound by the XRITC conjugated goat anti-rat IgE Ab and are visible by
immunofluorescence microscopy using a 546nm filter.
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Fig. 1 Dual-Expressing B Cells in the Small Intestine, Spleen, MLN, PP-NGC, and
PP-GC of Trichinella spiralis Infected Rats
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Fig 1 Contd.

G.

H.

Fig. 1 Dual-Expressing B Cells in the Small Intestine, Spleen, MLN, PP-NGC, and
PP-GC of Trichinella spiralis Infected Rats: Tissues were labeled with monoclonal
mouse-anti-rat IgGl Ab, and FITC-conjugated goat-anti-mouse IgG [H&L chain specific
(F(ab)2J fragment)]: XRITC-conjugated goat-anti-rat IgE Ab [H chain specific (F(ab)2’
fragment)] in a 1:1 ratio. (A, C, E, G, I) IgGl-expressing B cells localized within a field
[villus crypt unit (VCU) in the small intestine] as observed @ 400X magnification using
a 495nm filter specific for viewing FITC. (B, D, F, H, J) IgE-expressing B cells localized
within the identical villus crypt unit (VCU) as observed @ 400X magnification using a
546nm filter specific for viewing XRITC. (A, B) Small intestine; (C, D) spleen; (E, F)
MLN; (G, H) PP-NGC; (I, J) PP-GC. The intestinal tissue was obtained on day 7, and
the other tissues were obtained on day 10. The diameters of the labeled cells are between
10-12pm.
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3.1 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single Ab-

Expressing B Cells in the Small Intestine:

Intestinal samples labeled with specific monoclonal mouse anti-rat IgA, IgM,
IgGl, IgG2a, IgG2b, and IgG2c Ab respectively, and goat anti-rat IgE Ab showed a
significant increase in the number of double-labeled B cells per VCU by day 3 of
infection (Fig.. 2-7). This significance was maintained for the remainder of the experiment

as compared to the day 0 controls. There were no significant differences for different
dual Ab-combinations between respective days of infection throughout the duration of
the experiment. The number of IgAilgE dual-expressing B cells (Debc) (Fig. 2) showed

a significant increase on average per villus by day 3 (3.4+1.15), with a maximum on day

7 (28.13±3.52) compared to the controls (0.30±0.45). On day 0 IgMTgE-Debc in the
small intestine were less than (0.08±0.11) that of IgM single expressing B cells (Sebc)
(0.23±0.14) on average per villus (Fig. 3), although the differences were not significant.

IgMTgE-Debc were significantly increased in number as of day 3 of infection
(3.83±2.02) with the highest number of B cells per villus detected on day 7 (26.32+8.2)

and day 10 (24.15+4.61) (Fig. 3). IgGl TgE-Debc showed the greatest amount of dual-

Ab expressing B cells per villus with day 7 (28.53+3.26) and day 10 (29.01±3.87) being
the peak days of infection (Fig. 4). A significant increase over the day 0 (0.21+0.18)

occurred after day 3 of infection (3.79+3.87) (Fig. 4). IgE:IgG2a, IgE:IgG2b, and
IgE:IgG2c-Debc also showed similar significant increases in quantity from day 3 of
infection (5.35+2.50,4.79+2.28, 3.38+1.22, respectively) on through the end of the study
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Fig. 2 Kinetics of the Appearance of lgA:lgE Dual-Expressing B Cells, IgA Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Small Intestine: Rats were infected with 2,000
Trichinella spiralis muscle larvae on day 0. Samples of the small intestine 15cm from the pylorus were
removed on the indicated days post infection and immunohistochemically processed to reveal IgA-lgEDebc, IgA-Sebc, or IgE-Sebc in the small intestine. Data represent means ± standard deviation (SD) of
6 rats per day per villus crypt unit (VCU).
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Fig. 3 Kinetics of the Appearance of IgMdgE Dual-Expressing B Cells, IgM Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental procedures are
described in Fig. 2 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the small intestine. Data
represent means ± SD of 6 rats per day per VCU.
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Fig. 4 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental procedures are
described in Fig. 2 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the small intestine. Data
represent means ± SD of 6 rats per day per VCU.
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Fig. 5 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental
procedures are described in Fig. 2 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the small
intestine. Data represent means ± SD of 6 rats per day per VCU.
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Fig. 6 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental
procedures are described in Fig. 2 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the small
intestine. Data represent means ± SD of 6 rats per day per VCU.

lgG2c:lgE Labeled B Cells in the Small Intestine

—#—lgG2c:lgE
- - B- - - IgE

-

- lgG2c

GO
ro

Fig. 7 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Cells, lgG2c SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Small Intestine: Experimental
Procedures are described in Fig. 2 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the small
intestine. Data represent means ± SD of 6 rats per day per VCU.
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0.72 ±0.61
21.76 ±5.45abc
0.44 ± 0.26
12.33 ±2.51abc
0.13±0.13

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgM only
0.23 ±0.14
0.19 ±0.12
0.18 ±0.06
0.04 ± 0.08
0.75 ± 0.06
0.51 ± 0.34
0.08 ± 0.07
lgG2a only
0.00 ±0.00
0.08 ±0.13
0.06 ±0.06
0.02 ± 0.03
0.60 ± 0.25
0.33 ±0.24
0.11 ±0.07
lgG2c only
0.00 ± 0.00
0.06 ± 0.07
0.08 ±0.12
0.00 ± 0.00
0.61 ± 0.21
0.35 ± 0.23
0.14 ±0.05

IgE only
0.02 ± 0.03
0.09 ± 0.22
0.06 ±0.10
0.03 ± 0.04
0.53 ± 0.20
0.35 ±0.21
0.11 ±0.16
IgE only
0.00 ± 0.00
0.00 ± 0.00
0.01 ± 0.02
0.00 ± 0.00
0.44 ±0.32
0.38 ± 0.25
0.20 ±0.10
IgE only
0.00 ± 0.00
0.00 ± 0.00
0.05 ± 0.08
0.01 ± 0.02
0.57 ± 0.35
0.33 ±0.19
0.29 ±0.07

|

IgM & IgE
0.08 ±0.11
0.56 ± 0.46
3.83 ± 2.02ABC
6.18±2.76abc
26.32 ± 8.20abg
24.15 ±4.61abc
12.25 ± 2.84abc
| lgG2a & IgE
0.08 ± 0.09
0.30 ± 0.37
5.35 ± 2.50abc
5.45±1.65abc
23.99 ± 5.75abc
24.76 ± 3.46abc
13.87 ±3.38abc
| lgG2c & IgE
0.28 ± 0.26
0.42 ± 0.52
3.38 ± 1.22abc
5.51 ±1.1 5abc
25.23 ± 4.22abc
22.79 ± 4.62abc
16.31 ± 3.05abc

Table 1 Summary of the means ± standard deviations per VCU of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the small intestine. A Indicates a significant increase in Ig-

Debc over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @
p<0.05. c Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05.
Significance was determined according to Newman-Keuls Multiple-Range Test.

Table 2: Two-Factor ANOVA Comparisons in the Small Intestine
Two-Factor ANOVA: Comparison of the Different Dual AbExpressing B Cell Combinations in the Small Intestine
Source
df MS
7=
P-value F crit
SS
19.23

Dual-Ab Effect

96.14

5

Day Effect

26175.3

6

Interaction

419.84

30

13.99

Within

1990.44 210

9.48

Total

28681.8 251

2.03

4362.6 460.27
1.48

0.08

2.26

<0.0001

2.14

0.06

1.51

Two-Factor ANOVA: Comparison Between lgA:lgE-Debc,
IgA-Sebc, and IgE-Sebc in the Small Intestine
Source
F '
df MS
SS
P-value Fcrit
Ab Effect

3076.00

2

1538.0 434.67

<0.0001

3.08

Day Effect

1525.65

6

254.27 71.86

<0.0001

2.19

Interaction

2682.45 12 223.54 63.18

<0.0001

1.85

Within

371.52 105

Total

7655.62 125

3.54

Two-Factor ANOVA: Comparison Between lgM:lgE-Debc,
IgM-Sebc, and IgE-Sebc in the Small Intestine
Source
SS
df MS
F
P-value F crit
Ab Effect

Day Effect
Interaction

2944.54
1523.43
2740.81

2

1472.3 284.20
6 253.90 49.01
12 228.40 44.09

Within

543.94 105

Total

7752.71 125

<0.0001

3.08

<0.0001
<0.0001

2.19

1.85

5.18

Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the Small Intestine
Source
SS
df MS
F
P-value Fcrit
Ab Effect
3803.45 2 1901.7 897.50 <0.0001 3.08
Day Effect
2084.16 6 347.36 163.93 <0.0001 2.19
Within

3647.08 12 303.92 143.43
222.49 105 2.12

Total

9757.17 125

interaction

34

<0.0001

1.85

Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the Small Intestine
Ab Effect

df MS
F
SS
3010.92 2 1505.5 479.69

P-value
<0.0001

F crit
3.08

Day Effect

1423.32

6 237.22 75.59

<0.0001

2.19

Interaction

2546.74 12 212.23 67.62

<0.0001

1.85

Source

Within

329.53 .105

Total

7310.51 125

3.14

Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the Small Intestine
Source
df MS
SS
F
P-value F crit
Ab Effect

2614.73

1307.4 483.15

<0.0001

3.08

Day Effect

1604.37 6 267.39 98.82
2745.47 12 228.79 84.55

<0.0001

2.19

<0.0001

1.85

Interaction

2

Within

284.12 105

Total

7248.69 125

2.71

Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the Small Intestine
Source
SS
df MS
F
P-value F crit
Ab Effect
Day Effect
Interaction

Within

3017.62 2 1508.8 611.93
1474.18 6 245.70 , 99.65
2628.11 12 219.01 88.82
258.89 105 2.47 •

Total

7378.80 125

<0.0001
<0.0001

<0.0001

3.08
2.19
1.85

Table 2. Two-factor ANOVA comparing the various Ab-expressing B cell
combinations in the small intestine of rats. The comparisons resulting in
significant F values were then subjected to a Student-Newman Keuls test to
determine any significant differences between groups. The values of p<0.05
were considered significant.
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controls (0.08±0.09, 0.10+0.12, and 0.28±0.26, respectively) (Fig. 5-7). IgG2a:IgE-Debc
revealed the maximum on day 10 of infection (24.76±3.46) (Fig. 5), where as IgG2b:IgEDebc (Fig. 6), and IgG2c:IgE-Debc (Fig. 7) showed a maximum proliferation on day 7 of

infection (27.39±3.06 and 25.23±4.22). All of the dual Ab-combinations shown in this

experiment had a significant decrease per villus on day 15 of infection as compared to the
peak days of augmentation on day 7 and day 10, but the numbers of B cells were still
significantly increased over the controls (Fig. 2-7). When comparing the respective IgE-

Sebc, the IgA, IgM, IgGl, IgG2a, IgG2h, and IgG2c-Sebc, and the IgA, IgM, IgGl,
IgG2a, IgG2b, and IgG2c-Debc, there were significant increases for all of the dual

expressing B cells over the respective single-expressing B cells as of day 3 of infection,
and such significance remained for the duration of the experiment (Fig. 2-7).

Significance for dual Ab-expressing B cells in the small intestine, as compared to the day
0 controls, and between IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Sebc,
and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc was determined using a twofactor ANOVA. Differences resulting in significant F values were then subjected to a
Student Newman-Keuls multiple-range test and are presented in Table 1 and Table 2.

3.2 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single AbExpressing B Cells in the Spleen:
Spleen samples labeled with specific monoclonal mouse anti-rat IgA, IgM, IgGl,

IgG2a, IgG2b, and IgG2c Ab respectively, and goat anti-rat IgE showed a significant
increase in the number of double-labeled cells per field by day 5 of infection (Fig. 8-13).
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This significance was maintained for the remainder of the experiment as compared to the

day 0 controls. There were no significant differences for different dual Ab-combinations

between respective days of infection throughout the duration of the experiment. IgATgE
Debc showed significant increase per field over the control (0.27±0.30) on day 5 of

infection (5.77±4.01) with a maximum value at day 10 (10.68±3.17) (Fig. 8). IgA-Sebc
were very low per field in the spleen throughout the experiment with a maximum on day
7 (0.28±0.12), and significantly less than the dual-expressing B cells as of day 1 of
infection (0.03±0.05 for Sebc; 0.64±0.14 for Debc). IgM:IgE-Debc showed similar

results to IgA:IgE-Debc with day 5 being significantly greater than day 0 (6.17+2.81;
0.53+0.33), and day 10 (10.51±3.41) being the maximum day of proliferation of dual-Ab

expressing B cell (Fig. 9). IgGl :IgE-Debc showed the highest increase per field of dual
expressing B cells on day 10 of infection (13.74+3.38), with the significant increase per

field over the control (0.58+0.21) as of day 5 (6.20+3.45) (Fig.10). IgG2a:IgE-Debc also
reached their highest proliferation on day 10 (11.21+2.02) with day 5 being the first day

of significant increase over the control (5.58+5.44 for day 5; 0.36+0.40 for day 0) (Fig.
11). IgG2b:IgE-Debc and IgG2c:IgE-Debc showed similar numbers of B cells detected

per field and similar patterns of significant differences compared to the controls (Fig. 12

and 13). B cells on Day 5 (5.38+3.72 for IgG2b:IgE-Debc; 5.63+4.46 for IgG2c:IgEDebc) showed significant increase over the controls (0.43+0.30 for IgG2b:IgE-Debc;

0.38+0.23 for IgG2c:IgE-Debc), and the peak day of proliferation of these cells was on
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Fig. 8 Kinetics of the Appearance of IgAJgE Dual-Expressing B Cells, IgA Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Spleen: Rats were infected with 2,000 Trichinella
spiralis muscle larvae on day 0. Samples of the spleen were removed on the indicated days post
infection and immunohistochemically processed to reveal lgA:lgE-Debc, IgA-Sebc, or IgE-Sebc in the
spleen. Data represent means ± standard deviation (SD) of 6 rats per day per field.
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Fig. 9 Kinetics of the Appearance of IgMdgE Dual-Expressing B Cells, IgM Single-Expressing B
Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures are described in
Fig. 8 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the spleen. Data represent means + SD of 6
rats per day per field.
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Fig. 10 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures
are described in Fig. 8 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the spleen. Data represent
means ± SD of 6 rats per day per field.
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Fig. 11 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures
are described in Fig. 8 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the spleen. Data
represent means ± SD of 6 rats per day per field.
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Fig. 12 Kinetics of the Appearance of lgG2b.TgE Dual-Expressing B Cells, lgG2b SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental procedures
are described in Fig. 8 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the spleen. Data
represent means ± SD of 6 rats per day per field.
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Fig. 13 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Ceils, lgG2c SingleExpressing B Cells, and IgE Single-Expressing B Cells in the Spleen: Experimental Procedures
are described in Fig. 8 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the spleen. Data
represent means + SD of 6 rats per day per field.

Number of Ab-Expressing B Cells in the Spleen
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3

5
7
10
15

IgA only
0.10 + 0.10
0.03 ± 0.05
0.04 ± 0.08
0.09 ±0.16
0.28 + 0.12
0.08 ±0.10
0.16 ±0.12
lgG1 only
0.58 ± 0.56
0.28 ±0.10
0.16 ±0.06
0.08 ±0.08
0.29 ± 0.25
0.12 ±0.11
0.21 ±0.15
lgG2b only
0.10±0.10
0.05 ± 0.08
0.07 ± 0.04
0.10 ±0.13
0.23 ±0.18
0.08 ± 0.09
0.16 ±0.19

IgE only
0.02 ± 0.03
0.00 ± 0.00
0.06 ± 0.04
0.11 ±0.16
0.22 ±0.14
0.08 ± 0.06
0.12±0.18
IgE only
0.12 ±0.03
0.00 ± 0.00
0.03 ± 0.04
0.02 ± 0.03
0.16±0.13
0.07 ± 0.04
0.12 ± 0.11
IgE only
0.01 ± 0.02
0.01 ± 0.04
0.05 ±0.06
0.03 ± 0.04
0.15 ±0.10
0.08 ± 0.08
0.05 ± 0.06

IgA & IgE
0.37 ± 0.30
0.72±O.14ab
0.97 ± 0.08AB
5.77±4.01abc
4.77 ± 1.36ABC
10.68 ± 3.1 7abc
7.25 ± 2.20abc
lgG1 & IgE
0.58 ± 0.21
0.75 ± 0.76
0.09 ± 0.04
6.20 ± 3.45ABC
4.71 ± 1.38ABe
13.74 ± 3.38abc
7.88 ± 2.40ABC
lgG2b & IgE
0.43 ± 0.30
0.20 ±0.17
0.08 ±0.05
5.38±3.72abc
5.16 ± 1.03ABC
12,17 ±3.36abc
7.26 ± 1.93abc

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7 '
10
15

IgM only
0.39 ± 0.27
0.48 ± 0.27
0.23 ±0.12
0.10 ±0.12
0.36 ± 0.25
0.08 ± 0.09
0.12 ±0.10
IgG 2a only
0.05 ± 0.08
0.08 ±0.10
0.07 ± 0.06
0.33 ±0.65
0.30 ±0.14
0.12±0.11
0.11 ±0.23
lgG2c only
0.03 ± 0.06
0.03 ± 0.05
0.08 ±0.03
0.13 ±0.09
0.37 ± 0.22
0.11 ±0.09
0.17 ±0.15

IgE only
0.18 ±0.04
0.00 ±0.00
0.04 ±0.04
0.27 ±0.26
0.23 ±0.17
0.12 ±0.16
0.14 ±0.09
IgE only
0.02 ±0.03
0.00 ± 0.00
0.06 ± 0.06
0.04 ±0.05
0.13 ±0.10
0.09 ± 0.08
0.18 ±0.16
IgE only
0.03 ± 0.03
0.00 ±0.00
0.05 ±0.03
0.09 ±0.10
0.22 ±0.13
0.18 ±0.10
0.06 ± 0.09

IgM & IgE
0.53 ± 0.33
0.20 ±0.18
0.10 ±0.06
6.17±2.81abc
4.63 ± 1.38abc
10.51 ±3.41abc
7.05 ± 1.41abc
(gG2a & IgE
0.36 ± 0.40
0.08 ±0.12
0.09 ± 0.07
5.58 ± 5.44ABC
4.97 ± 1.34ABQ
11.21 ±2.02abc
9.35 ± 2.89abc
lgG2c & IgE
0.38 ± 0.23
0.07 ±0.08
0.16 ±0.12
5.63 ± 4.46ABC
5.19±0.54abc
11.93 ±1,54abc
7.08 ± 2.77ABC

Table 3 Summary of the means + standard deviations per field of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the spleen. A Indicates a significant increase in Ig-Debc

over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was
determined according to Newman-Keuls Multiple-Range Test.

Table 4: Two-Factor ANOVA Comparisons in the Spleen
Two-Factor ANOVA: Comparison of the Different Dual Ab
Expressing B Cell Combinations in the Spleen
Source
df
SS
MS
F
P-value F crit
Dual-Ab Effect

5

Day Effect

13.04
4213.25

Interaction

61.17

30

2.04

Within

964.12 210

4.59

Total

5251.58 251

6

2.61

0.57

702.21 152.95
0.44

0.72

2.26

<0.0001

2.14

1.00

1.51

Two-Factor ANOVA: Comparison Between lgA:lgE-Debc,
IgA-Sebc, and IgE-Sebc in the Spleen
Source
df MS
SS
F
P-value F crit
Ab Effect

469.96

2

234.98 147.13

<0.0001

3.08

Day Effect

200.77
399.75

6

33.46

20.95

<0.0001

2.19

12

33.31

20.86

<0.0001

1.85

Within

167.70 105

1.60

Total

1238.19 125

Interaction

Two-Factor ANOVA: Comparison Between lgM:lgE-Debc,
IgM-Sebc, and IgE-Sebc in the Spleen
Source
SS
df MS
F
P-value F crit
Ab Effect
465.10 2 232.55 206.21 <0.0001 3.08
Day Effect

197.57

32.93

29.20

<0.0001

2.19

Interaction
Within

387.63 12 32.30
118.41 105 1.13

28.64

<0.0001

1.85

Total

6

1168.72 125

Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the Spleen
Source

SS

df

Ab Effect

624.02

2

312.01 203.63

Day Effect

293.17

6

48.86

Interaction
Within

594.54 12 49.54
160.88 105 1.53

Total

MS

1672.62 125
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F

P-value

F crit

<0.0001

3.08

31.89

<0.0001

2.19

32.33

<0.0001

1.85

Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the Spleen
Source

df MS
F
2 263.04 123.30

P-value

F crit

Ab Effect

SS
526.08

<0.0001

3.08

Day Effect

257.66

6

20.13

<0.0001

2.19

19.50

<0.0001

1.85

Interaction

499.13

12

Within

224.00 105

Total

1506.88 125

42.94
41.59
2.13

Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the Spleen
Source
SS
df MS
F
P-value F crit
Ab Effect
Day Effect

506.90

Interaction
Within

480.69

Total

252.65

2
6

253.45 176.16
42.11 29.27

12 40.06
151.07 105 1.44

27.84

<0.0001

3.08

<0.0001

2.19

<0.0001

1.85

1391.31 125

Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the Spleen
Source
SS
df MS
P-value Fcrit
F '
506.95 2 253.48 174.59 <0.0001 3.08
Ab Effect
Day Effect
Interaction
Within
Total

239.84

6

39.97
474.94 12 39.58
152.45 105 1.45

27.53
27.26

<0.0001
<0.0001

2.19
1.85

1374.18 125

Table 4. Two-factor ANOVA comparing the various Ab-expressing B cell
combinations in the spleen of rats. The comparisons resulting in significant F
values were then subjected to a Student-Newman Keuls test to determine
any significant differences between groups. The values of p<0.05 were
considered significant.
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day 10 (12.17+3.36 for IgG2b:IgE-Debc; 11.93±1.54 for IgG2c:IgE-Debc) for each
combination. All of the dual Ab-combinations except for IgG2a:IgE-Debc showed a

significant decrease on day 15 of infection as compared to the peak days of infection on

day 10 (Fig. 8-13). When comparing the respective IgE-Sebc, the IgA, IgM, IgGl,
IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc,

there were significant increases for the dual-expressing B cells over the respective single

expressing B cells, except IgA:IgE-Debc to IgA-Sebc and IgE-Sebc, as of day 5 of
infection, and such significance remained for the duration of the experiment (Fig. 8-13).

Significance for dual Ab-expressing B cells in the spleen, as compared to the day 0
controls, and between IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Sebc, and
the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc was determined using a two-factor

ANOVA. Differences resulting in significant F values were then subjected to a Student
Newman-Keuls multiple-range test and are presented in Table 3 and Table 4.

3.3 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single AbExpressing B Cells in the Mesenteric Lymph Node:
Mesenteric Lymph Node (MLN) samples labeled with specific monoclonal mouse

anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c Ab respectively, and goat anti-rat IgE

showed a significant increase in the number of double-labeled B cells per field by day 7
of infection (Fig. 14-19). This significance was maintained for the remainder of the

experiment as compared to the day 0 controls. There were no significant differences for
different dual Ab-combinations between respective days throughout the duration of the
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experiment. IgA:IgE-Debc showed significant increase per field over the control
(0.95±0.52) on day 7 of infection (4.91 ±1.50) with a maximum reached on day 10

(13.23+3.52) (Fig. 14). IgM:IgE-Debc showed similar results to IgA.TgE-Debc with day

7 being significantly greater than day 0 (3.31+2.64; 0.39+0.56), and day 10 (13.18+6.34)

being the maximum day of augmentation of dual-Ab expressing B cells (Fig. 15).
IgGl :IgE-Debc showed a significant increase of dual-expressing B cells on day 7 of
infection (4.39+1.35), but the peak day of dual Ab expression happened on day 15

(9.35+2.40) rather than day 10 like the other dual-Ab combinations in this tissue (Fig.

16). IgG2a:IgE-Debc and IgG2b:IgE-Debc showed similar dynamics of activation to the
IgA:IgE-Debc and IgM:IgE-Debc with day 7 (3.43+2.28 for IgG2a:IgE-Debc and
3.66+1.53 for IgG2b:IgE-Debc) demonstrating significant proliferation of B cells, and

day 10 (8.48+4.01 for IgG2a:IgE-Debc and 10.25+3.58 for IgG2b:IgE-Debc) being the

peak day of proliferation (Fig. 17-18) . Similar results were obtained in the number of
IgG2c:IgE-Debc to that of the IgGl :IgE-Debc, but the values showed less overall

activation. Day 7 (3.32+1.76) was the first day of significant increase over the control
(1.11+0.39), and day 15 (7.25+2.77) was the peak day of activation (Fig. 19). ). When

comparing the respective IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Sebc,
and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc, there were significant increases
for all of the dual-expressing B cells over the respective single-expressing B cells, except
IgA:IgE-Debe to IgA-Sebc, as of day 3 of infection, and such significance remained for
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Fig. 14 Kinetics of the Appearance of lgA:lgE Dual-Expressing B Cells, IgA Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the Mesenteric Lymph Node (MLN): Rats were
infected with 2,000 Trichinella spiralis muscle larvae on day 0. Samples of the MLN were removed on
the indicated days post infection and immunohistochemically processed to reveal lgA:lgE-Debc, IgASebc, or IgE-Sebc in the MLN. Data represent means + standard deviation (SD) of 6 rats per day per
field.
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Fig. 15 Kinetics of the Appearance of IgMJgE Dual-Expressing B Cells, IgM Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental procedures are described in
Fig. 14 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the MLN. Data represent means ± SD of 6
rats per day per field.
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Fig. 16 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 SingleExpressing B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental procedures are
described in Fig. 14 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the MLN. Data represent
means + SD of 6 rats per day per field.
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Fig. 17 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a SingleExpressing B Cells, and IgE Single-Expressing B Ceils in the MLN: Experimental procedures are
described in Fig. 14 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the MLN. Data represent
means ± SD of 6 rats per day per field.
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Fig. 18 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b SingleExpressing B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental procedures are
described in Fig. 14 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the MLN. Data represent
means + SD of 6 rats per day per field.
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Fig. 19 Kinetics of the Appearance of igG2c:lgE Dual-Expressing B Cells, lgG2c SingleExpressing B Cells, and IgE Single-Expressing B Cells in the MLN: Experimental Procedures are
described in Fig. 14 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the MLN. Data represent
means + SD of 6 rats per day per field.

Numbers of Ab-Expressing B Cells in the Mesenteric Lymph Node

Ol
tn

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgA only
1.48 ±0.14
0.25 ±0.16
1.37 ±0.10
0.98 ± 0.36
0.01 ± 0,00
0.06 ± 0.02
0.12 ±0.12
lgG1 only
0.33 + 0.08
0.13 ±0.03
0.19 ±0.45
0.00 ± 0.20
0.00 ± 0.00
0.03 + 0.00
0.20 ±0.15
lgG2b only
0.11 ±0.08
0.05 ± 0.08
0.46 ±0.17
0.00 ± 0.02
0.00 ± 0.00
0.07 ± 0.06
0.17 ±0.19

IgE only
0.20 ±0.02
0.02 ± 0.06
0.10 ±0.02
0.28 ±0.19
0.01 ± 0.00
0.04 ± 0.06
0.14 ±0.18
IgE only
0.23 ± 0.04
0.19 ±0.07
0.03 ±0.04
0.01 ± 0.00
0.00 ± 0.00
0.13 ±0.07
0.18±0.11
IgE only
0.08 ± 0.00
0.00 ± 0.04
0.01 ±0.10
0.02 ± 0.03
0.00 ±0.00
0.02 ± 0.06
0.06 ±0.06

I

IgA & IgE
0.95 ± 0.74
0.14 ±0.04
2.61±1.00B
1.77±0.42b
4.91±1.50abc
13.23 ±3.52abc
7.05 ± 2.20abc
lgG1 & IgE
0.73 ± 0.53
0.64 ± 0.42
2.01±1.75ab
1.21 ± 0.57ab
4.39±1.35abc
8.16±1.64abc
9.35 ± 2.40ABC
lgG2b & IgE
0.58 ± 0.24
0.27 ± 0.27
1.78±1.22AB
1.04±0.92ab
3.66±1.53abc
10.25 ±3.58abc
7.08±1.93abc

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgM only
0.18 ±0.21
0.23 ± 0.22
0.39 ± 0.20
0.08 ±0.16
0.00 ± 0.02
0.00 ± 0.05
0.21 ±0.10
lgG2a only
0.05 ± 0.03
0.03 ±0.14
0.23 ± 0.22
0.01 ± 0.00
0.00 ±0.00
0.04 ± 0.06
0.16 ±0.23
lgG2c only
0.61 ± 0.02
0.28 ±0.12
0.23 ± 0.62
0.02 ± 0.00
0.00 ± 0.00
0.01 ± 0.08
0.16 ±0.15

IgE only
0.03 ± 0.00
0.05 ± 0.04
0.03 ± 0.22
0.00 ± 0.00
0.00 ± 0.02
0.04 ± 0.05
0.12 ±0.09
IgE only
0.00 ± 0.06
0.03 ± 0.05
0.07 ±0.06
0.02 ± 0.02
0.00 ± 0.00
0.03 ±0.24
0.05 ±0.16
IgE only
0.00 ±0.03
0.04 ±0.00
0.18 ±0.02
0.00 ± 0.05
0.00 ± 0.00
0.05 ± 0.03
0.12 ±0.09

IgM & IgE
0.39 ± 0.56
0.31 ± 0.08
2.35±1.72AB
1.56±0.80ab
3.31 ± 2.64ABC
13,18 ±6.34abc
7.88 ± 1.41ABC
lgG2a & IgE
0.39 ± 0.27
0.05 ± 0.66
1.37±1.54AB
1.40±0.57ab
3.43 ± 2.28ABC
8.48 ± 4.01ABC
7.26 ± 2.89ABC
lgG2c & IgE
0.11 ±0.39
0.02 ± 0.29
1.48±0.54AB
1.14±0.35ab
3.32±1.76abc
6.99 ± 4.73ABC
7.25±2.77abc

Table 5 Summary of the means + standard deviations per filed of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the MLN. A Indicates a significant increase in Ig-Debc over

the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was
determined according to Newman-Keuls Multiple-Range Test.

Table 6: Two-Factor ANOVA Comparisons in the Mesenteric Lymph
Node
Two-Factor ANOVA: Comparison of the Different Dual AbExpressing B Cell Combinations in the MLN
Source

SS
57.85

df

Dual-Ab Effect
Day Effect

3081.25

6

Interaction

204.78

30

6.83

Within

880.16 210

4.19

Total

4224.03 251

5

MS
11.57

F

P-value

F crit

2.76

0.02

2.26

<0.0001

2.14

0.03

1.51

513.54 122.53
1.63

Two-Factor ANOVA: Comparison Between IgAJgE-Debc,
IgA-Sebc, and IgE-Sebc in the MLN
Source
SS
df MS
F
P-value Fcrit
Ab Effect
Day Effect

248.37
101.10

2
6

124.19 123.56
16.85 16.76

<0.0001

3.08

<0.0001

2.19

Interaction

213.07

12

17.76

<0.0001

1.85

Within

105.53 105

Total

668.08 125

17.67

1.01

Two-Factor ANOVA: Comparison Between lgM:lgE-Debc,
IgM-Sebc, and IgE-Sebc in the MLN
Source
SS
df MS
F
P-value F crit
Ab Effect
517.35 2 258.68 101.45 <0.0001 3.08
. Day Effect
249.74 6 41.62 16.32
<0.0001 2.19
Interaction

504.17

12

Within

267.73 105

Total

1538.99 125

42.01

16.48

<0.0001

1.85

2.55

Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the MLN
Source
df
F
P-value F crit
SS
MS
Ab Effect

457.67

2

228.84 330.68

<0.0001

3.08

Day Effect

270.69

6

45.12

65.19

<0.0001

2.19

Interaction

540.47

12

45.04

65.08

<0.0001

1.85

Within

72.66

105

0.69

Total

1341.50 125
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Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the MLN
Source

SS
378.89

df MS
F
2 189.44 120.10

P-value
<0.0001

F crit

Day Effect

155.51

6

25.92

16.43

<0.0001

2.19

Interaction

322.83

17.06

<0.0001

1.85

Ab Effect

12

26.90

Within

165.62 105

1.58

Total

1022.85 125

3.08

Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the MLN
Source
Ab Effect

Day Effect
Interaction

SS
268.28
139.18

274.64

df

P-value

F crit

2
6

<0.0001
<0.0001

3.08

F
MS
134.14 130.23
23.20 22.52
12 22.89 22.22

Within

108.15 105

Total

790.27 125

<0.0001

2.19
1.85

1.03

Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the MLN
Source
SS
df MS
F
P-value F crit

Within

335.41 2 167.71 103.85
171.78 6 28.63 17.73
347.29 12 28.94 17.92
169.56 105 1.61

Total

1024.05 125

Ab Effect
Day Effect
Interaction

<0.0001
<0.0001
<0.0001

3.08
2.19
1.85

Table 6. Two-factor ANOVA comparing the various Ab-expressing B cell
combinations in the MLN of rats. The comparisons resulting in significant F
values were then subjected to a Student-Newm'an Keuls test to determine
any significant differences between groups. The values of p<0.05 were
considered significant.
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the duration of the experiment (Fig. 14-19). IgA:IgE-Debc were significantly increased

over the IgA-Sebc on day 7 of infection (0.01+0.00 for IgA-Sebc and 4.91+1.50 for
IgA:IgE-Debc). Significance for dual Ab-expressing B cells in the MLN, as compared to

the day 0 controls, and between IgE-Sebc, the IgA, IgM, IgGl, IgG2a, IgG2b, and

IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc was determined

using a two-factor ANOVA. Differences resulting in significant F values were then
subjected to a Student Newman-Keuls multiple-range test and are presented in Table 5

and Table 6.

3.4 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single AbExpressing B Cells in the Non-Germinal Center Region of the Peyer’s Patches:
Samples of the non-germinal center regions of the Peyer’s patches (PP-NGC)

labeled with specific monoclonal mouse anti-rat IgA, IgM, IgGl, IgG2a, IgG2b, and
IgG2c Ab respectively, and goat anti-rat IgE showed a significant increase in the number
of double labeled cells per field by day 7 of infection (Fig. 20-25). This significance was
maintained for the remainder of the experiment as compared to the day 0 controls. There
were no significant differences for different dual Ab-combinations between respective

days throughout the duration of the experiment. IgA:IgE-Debc showed significant
increase over the control (0.11+0.08) on day 7 of infection (2.37+1.18) with a maximum
value at day 10 (3.65+1.00) (Fig. 20). Similar kinetics of proliferation were obtained in

IgM:IgE-Debc with day 7 being significantly greater than day 0 (2.56+1.06; 0.04+0.18),

and day 10 (2.86+2.67) being the maximum proliferation of dual-Ab expressing B cell
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(Fig. 21). IgGl TgE-Debc showed a significant increase on day 7 of infection

(2.78+2.17) when compared to the control (0.07+0.08), and this was also the peak day of
proliferation (Fig. 22). IgG2a:IgE-Debc showed maximum augmentation on day 7

(2.07+2.05) which was the first day of significant increase over the control (0.09+0.06).
Similar numbers of B cells were also found on day 15 (2.50+1.08) (Fig. 23). IgG2b:IgE-

Debc like IgGl TgE-Debc had the highest increase in dual-expressing B cells on day 7

(3.76+1.22) of infection, and this was also the first day of significant increase per field

over the control (0.03+0.13) (Fig. 24). The final combination, IgG2c:IgE-Debc, was
increased significantly on day 7 (2.29+2.76), and this was also the peak day of
proliferation (Fig. 25). When comparing the respective IgE-Sebc, the IgA, IgM, IgGl,

IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc,

there were significant increases for all of the dual-expressing B cells over the respective

single-expressing B cells as of day 7 of infection, and such significant increases remained
for the duration of the experiment. Significance for dual Ab-expressing B cells in the PP-

NGC, as compared to the day 0 controls, and between IgE-Sebc, the IgA, IgM, IgGl,

IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2h, and IgG2c-Debc
was determined using a two-factor ANOVA. Differences resulting in significant F values

were then subjected to a Student Newman-Keuls multiple-range test and are presented in
Table 7 and Table 8.
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Fig. 20 Kinetics of the Appearance of IgA'.IgE Dual-Expressing B Cells, IgA Single-Expressing
B Ceils, and IgE Single-Expressing B Cells in the Non-Germinal Center Region of the Peyer's
Patch (PP-NGC): Rats were infected with 2,000 Trichinella spiralis muscle larvae on day 0. Samples
of the PP-ngc were removed on the indicated days post infection and immunohistochemically
processed to reveal lgA:igE-Debc, IgA-Sebc, or IgE-Sebc in the PP-NGC. Data represent means +_
standard deviation (SD) of 6 rats per day per field.
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Fig. 21 Kinetics of the Appearance of lgM:lgE Dual-Expressing B Cells, IgM Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures are
described in Fig. 20 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the PP-NGC. Data represent
means + SD of 6 rats per day per field.
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Fig. 22 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures
are described in Fig. 20 to reveal lgG1:lgE-Debc, lgG1-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 23 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures
are described in Fig. 20 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 24 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental procedures
are described in Fig. 20 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 25 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Cells, lgG2c SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-NGC: Experimental Procedures
are described in Fig. 20 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the PP-NGC. Data
represent means ± SD of 6 rats per day per field.

Numbers of Ab-Expressing B Cells in the Peyer's Patch - Non Germinal Centers

Ol
G)

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgA only
0.18 ±0.09
0.14 ±0.04
0.33 ± 0.32
0.08 ± 0.67
0.01 ± 0.04
0.01 + 0.06
0.02 ± 0.08
lgG1 only
0.01 ± 0.04
0.01 ± 0.00
0.03 ±0.11
0.17 ±0.07
0.02 ± 0.02
0.08 ± 0.03
0.05 ± 0.06
lgG2b only
0.01 ± 0.06
0.14 ±0.03
0.01 ± 0.08
0.23 ± 0.09
0.04 ±0.00
0.06 ± 0.05
0.02 ± 0.04

IgE only
0.00 ± 0.00
0.00 ± 0.00
0.41 ± 0.02
0.22 ±0.12
0.00 ± 0.03
0.01 ±0.10
0.04 ±0.06
IgE only
0.00 ± 0.02
0.01 ± 0.00
0.02 ± 0.04
0.14 ±0.03
0.00 ± 0.04
0.05 ± 0.05
0.04 ±0.06
IgE only
0.01 ± 0.00
0.12 ±0.02
0.02 ± 0.04
0.18±0.17
0.03 ± 0.06
0.07 ± 0.04
0.00 ± 0.03

I

IgA & IgE
0.11 ±0.08
0.42 ± 0.22
0.90 ±0.66
0.18 ±1.88
2.37 ±1.18ABC
3.65 ± 1.00ABC
2.59±1.59abc

lgG1 & IgE
0.07 ± 0.08
0.32 ± 0.30
1.40 ±0.25
0.40 ± 0.00
2.78±2.17abc
2.53±2.38abc
1.99 ± 1.24abc
lgG2b & IgE
0.03 ±0.13
0.48 ±0.14
0.93 ± 0.43
0.74 ± 0.23
3.76 ± 1.22abc
2.34±1.38abc
1.90 ± 1.31abc

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgM only
0.03 ±0.14
0.00 ±0.10
0.25 ±0.16
0.07 ± 0.08
0.01 ± 0.02
0.02 ± 0.02
0.05 ± 0.03
lgG2a only
0.05 ± 0.02
0.02 ± 0.02
0.06 ±0.14
0.29 ± 0.22
0.00 ± 0.03
0.04 ±0.10
0.05 ± 0.04
lgG2c only
0.15 ±0.02
0.14 ±0.09
0.53 ± 0.02
0.38 ± 0.22
0.03 ± 0.05
0.03 ± 0.07
0.04 ± 0.03

IgE only
0.01 ±0.00
0.00 ± 0.00
0.12 ±0.02
0.02 ± 0.25
0.02 ± 0.00
0.04 ± 0.02
0.08 ±0.05
IgE only
0.00 ± 0.00
0.01 ± 0.02
0.02 ± 0.04
0.17 ±0.09
0.05 ±0.00
0.03 ± 0.04
0.04 ± 0.05
IgE only
0.00 ± 0.02
0.10 ±0.03
0.21 ± 0.05
0.25 ±0.17
0.00 ± 0.04
0.05 ± 0.06
0.07 ± 0.00

IgM & IgE
0.04 ±0.18
0.37 ± 0.35
0.69 ± 0.43
0.08 ±0.18
2.56±1.06ABC
2.86 ± 2.67abc
2.43 ± 1.62abc
lgG2a & IgE
0.09 ± 0.06
0.16 ±0.32
1.00 ±0.91
0.32 ± 0.38
2.07 ± 2.05abc
2.39 ± 1.44ABG
2.50 ± 1.08ABC
lgG2c & IgE
0.05 ±0.06
0.40 ± 0.24
0.71 ±0.76
0.75 ±1.20
2.29 ± 2.76abc
1.86±1.46abc
2.09 ± 1.08abc

Table 7 Summary of the means + standard deviations per field of 6 ratsof the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the PP-NGC. A Indicates a significant increase in Ig-Debc

over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was
determined according to Newman-Keuls Multiple-Range Test.

Table 8:Two-Factor ANOVA Comparisons in the Non-Germinal Center
Regions of the Peyer's Patch
Two-Factor ANOVA: Comparison of the Different Dual AbExpressing B Cell Combinations in the PP-NGC
df

Dual-Ab Effect

SS
2.53

Day Effect

Interaction

F

P-value

F crit

5

MS
0.51

0.36

0.88

2.26

282.62

6

47.10

33.51

<0.0001

2.14

30.63,

30

1.02

0.73

0.85

1.51

Within

295.23 210

1.41

Total

611.00 251

Source

Two-Factor ANOVA:.Comparison Between lgA:lgE-Debc,
IgA-Sebc, and IgE-Sebc,in the PP-NGC
Source

SS

df

MS

Ab Effect

56.03

.2

Day Effect

13.11

6

2.18

Interaction

25.47

12

2.12

Within

45.88 105

0.44

Total

140.49 125

P-value

F crit
.3.08

5.00

<0.0001
<0.0001

4.86

<0.0001

1.85

F

28.02 , 64.11

2J9

Two-Factor ANOVA: Comparison Between lgM:lgE-Debc,
IgM-Sebc, and IgE-Sebc in the PP-NGC
Source
df MS
SS
F
P-value F crit
Ab Effect
56.52
2 28.26 52.40 <0.0001 3.08
23.44

6

3.91.

7.24

<0.0001

Interaction

47.26

12

3.94

7.30

<0.0001

Within

56.62 105

0.54

Total

183.85 125

Day Effect

2.19
1.85

Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the PP-NGC
Source
df MS
F
P-value F crit
SS
Ab Effect

41.09

2

20.55

33.91

<0.0001

3.08

Day Effect

17.64

6

2.94

4.85

<0.0001

2.19

12
63.62 105

3.37

5.57

<0.0001

1.85

Interaction

Within

Total

40.47

0.61

162.82 125
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Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the PP-NGC
Source
SS
df
F
MS
P-value F crit
Ab Effect

47.04

2

23.52

57.46

<0.0001

3.08

Day Effect

14.19

6

2.37

5.78

<0.0001

2.19

Interaction

30.79

12

2.57

6.27

<0.0001

1.85

Within

42.98 105

0.41

Total

135.01 125

Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the PP-NGC
Source

SS

df

MS

F

Ab Effect

36.99

2

18.49

70.47

P-value
<0.0001

Day Effect

12.16

6

2.03

7.72

<0.0001

Interaction

30.37

12

2.53

9.64

<0.0001

Within

27.55 105

0.26

Total

107.07 125

Fcrit

2.19
1.85

3.08

Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the PP-NGC
Source
SS
df MS
F
P-value Fcrit
Ab Effect

Day Effect
Interaction
Within
Total

55.25

2
6

27.62
3.32

44.42
5.34

<0.0001
<0.0001

3.08
2.19

40.81 12
65.30 105

3.40
0.62

5.47

<0.0001

1.85

19.94

181.29 125

Table 8. Two-factor ANOVA comparing the various Ab-expressing B cell
combinations in the PP-NGC of rats. The comparisons resulting in significant
F values were then subjected to a Student-Newman Keuls test to determine
any significant differences between groups. The values of p<0.05 were
considered significant.
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3.5 Kinetics of the Appearance of Dual Ab-Expressing B Cells and Single AbExpressing B Cells in the Germinal Center Region of the Peyer’s Patches:
Samples of the germinal center regions of the Peyer’s patches (PP-GC) were

labeled with specific monoclonal mouse anti-rat IA, IgM, IgGl, IgG2a, IgG2b, and
IgG2c, and goat anti-rat IgE. The results showed that the number of IgA:IgE-Debc were

significantly increased as compared to the controls (2.65±2.85) as of day 5 of infection
(9.78±4.78), and it remained significantly increased for the remainder of the experiment
(Fig. 26). Significant increase was also shown on day 10 (23.16±7.46) and day 15

(24.32±1.75) over the day 5 infected rats, and these were the peak days of B cell
proliferation. IgM:IgE-Debc showed a sharp significant increase as of day 1 of infection

(8.03±2.62 ). This was followed by a decrease on day 3 (3.97±3.85) that was not

significantly increased over the controls (Fig. 27). On day 7(11.22+1.28) the dual

expressing B cells were again significantly increased over the control, and remained
increased for the remainder of the experiment. IgGl :IgE-Debc and IgG2a:IgE-Debc
showed similar results in B cell proliferation, with a significant increase per field over the

controls (1,98±2.15 for IgGl:IgE-Debc; 2.71±3.11 for IgG2a:IgE-Debc) as of day 7

(10.04±1.23 for IgGl:IgE-Debc; 7.98±1.49 for IgG2a:IgE-Debc) of infection and such
kinetics remained throughout the duration of the experiment (Fig. 28 and 29,

respectively). IgG2b:IgE-Debc and IgG2c:IgE-Debc showed similar ranges of B cells

proliferation to that of the IgM:IgE-Debc. These two combinations showed sharp
significant increase as of day 1 of infection (6.50±2.25 for IgG2b:IgE-Debc; 5.84±1.75
for IgG2c:IgE-Debc), followed by a decrease on day 3 (3.97±2.03 for IgG2b:IgE-Debc;
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5.08±l .39 for IgG2c:IgE-Debc) of infection that was not significantly increased over the
respective controls (Fig. 30 and 31, respectively). On day 7 (8.14±1.03 for IgG2b:IgEDebc; 9.37±1.25 for IgG2c:IgE-Debc) the dual-expressing B cells were again

significantly increased over the control, and remained increased for the remainder of the
experiment. IgA-Sebc and IgM-Sebc were significantly higher than the other single Ab-

expressing B cells on day 1 and day 3 of infection, but became similar, with no
significant differences, to the other single Ab-expressing B cells as the days of infection
proceeded. As compared to the IgA:IgE-Debc, the number of IgA-Sebc was significantly
less per field than the dual-expressing B cells as of day 3 (1.05±0.56 for IgA-Sebc;

6.28+2.46 for IgA:IgE-Debc) of infection (Fig. 26). The kinetics of the numbers of IgMSebc were similar to that of IgA-Sebc, with day 3 being the first day significantly

declined compared to the IgM:IgE-Debc (0.56±0.70 for IgM-Sebc; 3.97±3.85 for
IgM:IgE-Debc) (Fig. 27). The numbers of IgGl-Sebc, IgG2a-Sebc, IgG2b-Sebc, and

IgG2c-Sebc were all significantly less than that of the respective dual-expressing B cells
for the entire experiment (Fig. 28, 29, 30, and 31 respectively). IgE-Sebc for each group

of rats was also significantly less in number than that of the respective dual-expressing B
cells for the entire experiment. Significance for dual Ab-expressing B cells in the PP-

GC, as compared to the day 0 controls, and between IgE-Sebc, the IgA, IgM, IgGl,

IgG2a, IgG2b, and IgG2c-Sebc, and the IgA, IgM, IgGl, IgG2a, IgG2b, and IgG2c-Debc
was determined using a two-factor ANOVA. Differences resulting in significant F values
were then subjected to a Student Newman-Keuls multiple-range test and are presented in
Table 9 and Table 10.
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Fig. 26 Kinetics of the Appearance of lgA:lgE Dual-Expressing B Cells, IgA Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the Germinal Center Region fo the Peyer's Patch
(PP-GC): Rats were infected with 2,000 Trichinella spiralis muscle larvae on day 0. Samples of the
. PP-GC were removed on the indicated days post infection and immunohistochemicaily processed to
reveal lgA:lgE-Debc, IgA-Sebc, or IgE-Sebc in the PP-GC. Data represent means ± standard deviation
(SD) of 6 rats per day per field.
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Fig. 27 Kinetics of the Appearance of lgM:lgE Dual-Expressing B Cells, IgM Single-Expressing
B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures are described
in Fig. 26 to reveal lgM:lgE-Debc, IgM-Sebc, or IgE-Sebc in the PP-GC. Data represent means ± SD
of 6 rats per day per field.
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Fig. 28 Kinetics of the Appearance of lgG1:lgE Dual-Expressing B Cells, lgG1 SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures
are described in Fig. 26 to reveal lgG1 :lgE-Debc, lgG1-Sebc, or IgE-Sebc in the PP-GC. Data
represent means ± SD of 6 rats per day per field.
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Fig. 29 Kinetics of the Appearance of lgG2a:lgE Dual-Expressing B Cells, lgG2a SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures
are described in Fig. 26 to reveal lgG2a:lgE-Debc, lgG2a-Sebc, or IgE-Sebc in the PP-GC. Data
represent means + SD of 6 rats per day per field.
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Fig. 30 Kinetics of the Appearance of lgG2b:lgE Dual-Expressing B Cells, lgG2b SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental procedures
are described in Fig. 26 to reveal lgG2b:lgE-Debc, lgG2b-Sebc, or IgE-Sebc in the PP-GC. Data
represent means + SD of 6 rats per day per field.
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Fig. 31 Kinetics of the Appearance of lgG2c:lgE Dual-Expressing B Cells, lgG2c SingleExpressing B Cells, and IgE Single-Expressing B Cells in the PP-GC: Experimental Procedures
are described in Fig. 26 to reveal lgG2c:lgE-Debc, lgG2c-Sebc, or IgE-Sebc in the PP-GC. Data
represent means ± SD of 6 rats per day per field.

Numbers of Ab-Expressing B Cells in the Peyer’s Patch - Germinal Centers

-J
~xj

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgA only
2.59 ±1.87
2.97 ±1.73
1.05 ±0.56
0.83 ± 2.04
0.08 ±0.11
0.31 ± 0.48
0.40 ± 0.29
lgG1 only
0.39 ± 0.56
0.49 ±0.42
0.44 ± 0.39
0.33 ± 0.52
0.08 ± 0.09
0.19 ±0.11
0.45 ±0.62
lgG2b only
0.38 ± 0.43
0.25 ±0.14
0.11 ±0.17
0.00 ±0.00
0.03 ± 0.05
0.15 ±0.12
0.46 ±0.89

IgE only
0.09 ±0.13
0.14 ±0.17
0.20 ± 0.32
0.00 ± 0.00
0.02 ± 0.05
0.18 ±0.27
0.27 ±0.19
IgE only
0.00 ± 0.00
0.40 ± 0.37
0.33 ±0.58
0.25 ± 0.27
0.07 ± 0.08
0.04 ± 0.07
0.12 ±0.16
IgE only
0.06 ± 0.09
0.20 ± 0.20
0.17 ±0.41
0.00 ± 0.00
0.03 ± 0.05
0.27 ± 0.41
0.05 ± 0.08

IgA & IgE
2.65 ± 2.85B
6.64 ± 2.24b
6.28 ± 2.46ab
9.78 ± 4.78abc
9.30 ± 3 09abc
23.16 ±7.46abc
24.32 ±1.75abc
lgG1 & IgE
1.98±2.15ab
6.35 ± 2.77ab
4.78 ± 3.30ab
3.17±1.97ab
10.04 ± 1.23abc
27.58 ± 6.03ABC
19.70 ±3.51abc
lgG2b & IgE
2.32 ± 1 ,98ab
6.50 ± 2.25abc
3.97 ± 2.03ab
5.83±3.50ab
8.14±1,03abc
21.70 ± 4.95abc
36.02 ± 7.67abc

DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15
DPI
0
1
3
5
7
10
15

IgM only
1.27 ±0.42
3.94 ± 3.63
0.56 ± 0.70
0.25 ±0.61
0.09 ±0.12
0.12 ±0.15
0.41 ± 0.65
lgG2a only
0.27 ± 0.42
0.09 ±0.15
0.32 ± 0.26
0.00 ±0.00
0,13±0.19
0.31 ± 0.34
0.22 ± 0.28
lgG2conly
0.14 ±0.12
0.25 ± 0.28
0.19 ±0-31
0.00 ± o.oo
0.08 ± 0.09
0.08 ±0.20
0.25 ±0.46

IgE only
0.02 ± 0.05
0.04 ± 0.10
0.29 ± 0.51
0.25 ±0.42
0.07 ±0.12
0.21 ± 0.28
0.48 ± 0.44
IgE only
0.03 ± 0.07
0.17 ±0.28
0.21 ±0.17
0.00 ± 0.00
0.02 ± 0.04
0.33 ± 0.54
0.25 ±0.17
IgE only
0.04 ± 0.06
0.05 ±0.12
0.35 ± 0.58
0.00 ± 0.00
0.01 ± 0.02
0.14±0.18
0.48 ± 0.53

IgM & IgE
2.88 ± 1,99B
8.03 ± 2.62abc
3.97 ± 3.85ab
5.58 ± 2.06ab
11.22 ± 1.28abc
17.85 ± 2.46ABC
30.45 ± 16.83abc
lgG2a & IgE
2.71±3.11AB
5.83 ± 3.52ab
6.49 ± 4.64AB
3.33±5.43ab
7.98±1.49abc
15.95 ± 3.34abc
23.06 ± 7.20abc
lgG2c & IgE
1.86±1.87ab
5.84 ± 1.75ABC
5.08 ± 1.39ab
3.33±5.13ab
9.37 ± 1.25abc
21.33 ±4.56abc
28.25 ± 14.30abc

Table 9 Summary of the means + standard deviations per field of 6 rats of the kinetics of appearance of
dual Ab, and single Ab expression by B cells in the PP-GC. A Indicates a significant increase in Ig-Debc
over the Ig-Sebc @ p<0.05. B Indicates a significant increase in Ig-Debc over the IgE-Sebc @ p<0.05. c
Indicates a significant increase in Ig-Debc over the day 0 control Ig-Debc @ p<0.05. Significance was
determined according to Newman-Keuls Multiple-Range Test.

Table 10: Two-Factor ANOVA Comparisons in the Germinal Center
Regions of the Peyer's Patches
Two-Factor ANOVA:. Comparison of the Different Dual AbExpressing B Cell Combinations in the PP-GC
Source

Dual-Ab Effect
Day Effect

SS : tff , MS
206.97
5 41.39

FP-value

2.71 <0.001

6 3154.6 130.14 <0.0001
18927.9
1618.83 30 53.96
2.23 <0.0001

Interaction
Within

5090.53 210

Total

25844.2 251

Fcrif
2.26

2.;14
1.51

24.24

Two-Factor ANOVA: Comparison Between lgA:lgE-Debc,
IgA-Sebc, and IgE-Sebc in the PP-GC
Source
df MS
F
P-value F crit
SS
3542.20
Ab Effect
2 1771.1 275.14 <0.0001
3.08
Day Effect
Interaction

Within
Total

844.81
1812.17

6 140.80

12 151.01

675.90 105

21.87 <0.0001
23.46 <0.0001

2.19

1.85

6.44

6875.07 125

Two-Factor ANOVA: Comparison Between lgM:lgE-Debc,
IgM-Sebc, and IgE-Sebc in the PP-GC
Source
SS
df MS
F
P-value F crit
Ab Effect
3471,55
2 1735.6 111.47 <0.0001
3.08
Day Effect
1145.80
6 190.97 12.26 <0.0001
2.19
Interaction

2324.76

Within

1635.00 105

Total

8577.11 125

12 193.73

12.44 <0.0001

1.85

15.57

Two-Factor ANOVA: Comparison Between lgG1:lgE-Debc,
lgG1-Sebc, and IgE-Sebc in the PP-GC
Source
df MS
SS
F
P-value F crit
Ab Effect

Day Effect
Interaction

2890.08
1082.77
2239.24

2 1445.0 357.11 <0.0001
6 180.46 44.60 <0.0001
12 186.60 46.11 <0.0001

Within

424.88 105

Total.

6636.97 125

4.05
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3.08

2.19
1.65

Two-Factor ANOVA: Comparison Between lgG2a:lgE-Debc,
lgG2a-Sebc, and IgE-Sebc in the PP-GC
Source
Ab Effect

Day Effect
Interaction

df
SS
MS
F
P-value
2279.04
2 1139.5 166.24 <0.0001
6 105.80 15.43 <0.0001
634.77

12 115.26

Within

1383.13
719.74 105

Total

5016.68 125

16.82 <0.0001

Fcrit

3.08

2.19

1.85

6.85

Two-Factor ANOVA: Comparison Between lgG2b:lgE-Debc,
lgG2b-Sebc, and IgE-Sebc in the PP-GC
Source
Ab Effect

Day Effect
Interaction

Within

Total

df MS
SS
F
P-value
3919.23
2 1959.6 366.82 <0.0001
1824.44
6 304.07 56.92 <0.0001
3653.90 12 304.49 57.00 <0.0001

560.93 105

F crit
3.08

2.19

1.85

5.34

9958.50 125

Two-Factor ANOVA: Comparison Between lgG2c:lgE-Debc,
lgG2c-Sebc, and IgE-Sebc in the PP-GC
Source
df MS
SS
F
P-value Fcrit
Ab Effect
3082.55
2 1541.3 121.98 <0.0001
3.08
Day Effect
1177.86
6 196.31 15.54 <0.0001
2.19
Interaction
2492.91 12 207.74 16.44 <0.0001
1.85
Within
1326.68 105 12.64
Total

8079.99 125

Table 10. Two-factor ANOVA comparing the various Ab-expressing B cell
combinations in the PP-GC of rats. The comparisons resulting in significant
F values were then subjected to a Student-Newman Keuls test to determine
any significant differences between groups. The values of p<0.05 were
considered significant.

79

3.6 Kinetics of the Appearance of 0X33 Labeled B Cells in the Small Intestine, Spleen,
Mesenteric Lymph Node, Peyer’s Patch-Non Germinal Center Regions, and Peyer’s

Patch-Germinal Center Regions:

To determine the total numbers of B cells in each of the organs and tissues
examined, AO rats were infected with 2,000 Trichinella spiralis muscle larvae on day 0.

Rats were randomly assorted into seven groups of six rats and tissues were taken from the

small intestine 15cm distal to the pylorus, the nearest Peyer’s patches, mesenteric lymph
node, and the spleen on days 0 (control), 1, 3, 5, 7, 10, and 15 after infection. Tissues
were cryo-histologically processed and then labeled with monoclonal mouse anti-rat

0X33 Ab conjugated with XRITC. The kinetics of the appearances of B cells were
examined by immunofluorescence microscopy and the 0X3 3+ cells appeared bright red

when using a 546nm filter as shown in Figure 32. The photographs are of samples from
the MLN (A), spleen (B), PP-NGC (C), PP-GC (D), and small intestine (E) on day 15

after infection.
Samples of the small intestine labeled with monoclonal mouse anti-rat 0X33 Ab
showed a significant increase in CD45RA+ B cells by day 3 of infection (7.57±2.15), as

compared to the day 0 controls (0.52±0.76) (Fig. 33). The number of B cells
continuously increased throughout the entire experiment, with the greatest number of B
cells detected on day 15 after infection (31.87±5.72). B cells found in the spleen showed

a much more delayed proliferative response to the Trichinella spiralis infection when
compared to the small intestine. Significant increase in OX33+ B cells was found on day

10 after infection (16.85±4.58) over the controls (6.04±1.64), with day 15 (22.58±5.20)
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being the peak day of proliferation (Fig. 34). MLN showed delayed proliferation of B
cells as well, with significant increase over the control (5.35±3.45) by day 5 after

infection (13.44+5.62) (Fig. 35). B cell proliferation continued in the MLN after day 5,

with a maximum amount found on day 15 after infection (29.41H2.66). The lowest degree
of B cell proliferation was detected in the PP-NGC (Fig. 36). Significant increase over
the control (2.01 ±1.47) took place on day 5 (7.87+3.12), followed by a slight decrease on

day 7 (7.08+4.84) that was not significantly different from the control (Fig. 36). In this
tissue, a significant increase in B cell number over the control occurred on day 10

(13.21+2.24), which was also the peak day of proliferation. The final tissue in which B
cells were enumerated was in the PP-GC. The PP-GC exhibited a high number of B cells

in the control (9.35+3.43), and infected rats showed a significant increase over the
controls on day 3 (18.23+4.94) (Fig. 37). Such significant proliferation maintained its

kinetics throughout the remainder of the experiment with a maximum number of B cells
quantified on day 15 (30.71+7.15). Significance for the number of OX 33 labeled B

cells, as compared to the controls, was determined using a one-factor ANOVA.

Differences resulting in significant F values were the subjected to a Student NewmanKeuls multiple-range test and are presented in Table 11 and Table 12.
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Fig. 32 Appearance of CD45RA Positive B Cells Detected by 0X33 Ab in the Small
Intestine, Spleen, MLN, PP-NGC, and PP-GC of Trichinella spiralis Infected Rats:
Tissues were labeled with monoclonal mouse-anti-rat OX 33 Ab conjugated with XRITC,
CD45RA+ B cells localized within a field [villus crypt unit (VCU) in the small intestine]
from (A) MLN, (B) spleen, (C) PP-NGC, (D) PP-GC, and (E) small intestine were
observed @ 400X magnification using a 546nm filter specific for viewing XRITC. The
diameters of the labeled cells are between 10-12pm.
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Fig. 33 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the Small Intestine: Rats were infected with 2,000 Trichinella spiralis muscle
larvae on day 0. Samples from the small intestine 15cm from the pylorus were removed on the

indicated days of infection and immunohistochemicaily processed to reveal CD45RA+ B cells in the
small intestine. Data represents means + standard deviation per VCU of 6 rats per day.
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Fig. 34 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the Spleen: Rats were infected with 2,000 Trichinella spiralis muscle larvae on
day 0. Samples from the spleen were removed on the indicated days of infection and
immunohistochemically processed to reveal CD45RA+ B cells in the spleen. Data represents means +
standard deviation per field of 6 rats per day.

00
cn

Fig. 35 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the MLN: Rats were infected with 2,000 Trichinella spiralis muscle larvae on day
0. Samples from the MLN were removed on the indicated days of infection and immunohistochemically

processed to reveal CD45RA+ B cells in the MLN. Data represents means + standard deviation per
field of 6 rats per day.
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Fig. 36 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the PP-NGC: Rats were infected with 2,000 Trichinella spiralis muscle larvae on
day 0. Samples from the PP-NGC were removed on the indicated days of infection and

immunohistochemically processed to reveal CD45RA+ B cells in the PP-NGC. Data represents means
± standard deviation per field of 6 rats per day.

Days Post Infection

Fig. 37 Kinetics of the Appearance of CD45RA Expressing B Cells Detected by 0X33
monoclonal Ab in the PP-GC: Rats were infected with 2,000 Trichinella spiralis muscle larvae on
day 0. Samples from the PP-GC were removed on the indicated days of infection and

immunohistochemicaily processed to reveal CD45RA* B cells in the PP-GC. Data represents means ±
standard deviation per field of 6 rats per day.

Numbers of CD45RA+ B Cells
Day Post
Day Post
Infection Sm. Intestine Infection

Spleen

Day Post
Infection

MLN

Day Post
Infection

PP-NGC

Day Post
Infection

PP-GC

0

0.52 + 0.76

0

6.04 ± 1.64

0

5.35 ± 3.45

0

2.01 ± 1.47

0

9.35 ± 3.43

1

4.33 + 2.09

1

6.70 ± 2.87

1

3.79 ±1.34

1

3.49 ± 2.02

1

10.43 ±3.58

3

7.57 ±2.15**

3

8.23 ±1.95

3

10.20 ±4.24

3

5.68 ± 3.02

3

18.23 ±4.94**

5

11.22 ±2.44**

5

3.94 ±1.81

5

13.44 ± 5.62**

5

7.87 ±3.12**

5

20.68 ± 6.95**

7

20.08 ± 5.62**

7

9.10 ±3.56

7

19.65 ± 8.73**

7

7.08 ±4.84

7

24.91 ± 5.77**

10

27.01 ± 2.99**

10

16.85 ±4.58**

10

24.77 ± 8.78**

10

13.21 ±2.24**

10

28.21 ± 5.56**

15

31.87 ±5.72**

15

22.58 ± 5.20**

15

29.41 ± 2.66**

15

10.89 ±4.59**

15

30.71 ±7.15**

Table 11 Summary of the mean ± standard deviations per field (per VCU in the Sm. Intestine) of 6 rats per day
of the kinetics of appearance of CD45RA* B cells in the small intestine, spleen, mesenteric lymph node, nongerminal center regions of the Peyer's patches, and the germinal center regions of the Peyer's patches on days
0 (control), 1, 3, 5, 7, 10, and 15 post infection. ** Indicates a significant increase over the control groups @
p<0.05 for each tissue. Significance was determined according to the Newman-Keuls Multiple-Range Test.

Table 12: One-Factor ANOVA Comparisons for 0X33 Labeled B Cells in
the Small Intestine, Spleen, MLN, PP-NGC, and PP-GC
One-Factor ANOVA: Total B Cell Count in the Small Intestine
Through OX33-Ab labeling
P-value
F
F crit
Source
df
MS
SS

Day Effect

5081.34

6

Within Groups

450.42

35

Total

846.89 65.81

<0.0001

2.37

12.87

5531.77 41

One-Factor ANOVA: Total B Cell Count in the Spleen
Through OX33-Ab labeling
P-value
Fcrit
Source
df
MS
F
SS
<0.0001
2.37
1624.53
6
270.76
24.06
Day Effect
Within Groups

Total

393.82

35

11.25

2018.35 41

One-Factor ANOVA: Total B Cell Count in the MLN Through
OX33-Ab labeling
P-value
F crit
df
F
Source
SS
MS
2.37
3410.75 6 568.46 17.78 <0.0001
Day Effect
Within Groups

1118.81 35

Total

4529.57 41

31.97

One-Factor ANOVA: Total B Cell Count in the PP-ngc
Through OX33-Ab labeling
Source
F
P-value
SS
df
MS
Fcrit
559.13 6 93.19 8.75
<0.0001
2.37
Day Effect
Within Groups

372.63

35

Total

931.76

41

10.65

One-Factor ANOVA: Total B Cell Count in the PP-GC Through
OX33-Ab labeling
P-value
Source
df
Fcrit
SS
MS
F
2.37
Day Effect
2482.69 6 413.78 13.62 <0.0001

Within Groups 1063.34 35

Total

30.38

3546.03 41

Table 12. One-factor ANOVA comparing CD45RA* B cells labeled with 0X33Ab in the small intestine, spleen, MLN, PP-NGC, and PP-GC for respective
days of infection in rats. The comparisons resulting in significant F values were
then subjected to a Student-Newman Keuls test to determine any significant
differences between groups. The values of p<0.05 were considered significant.
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4) Discussion

B-lymphocytes proliferating in the small intestine of rats against Trichinella
spiralis infection have been shown to produce nearly all Ab isotypes at some point during
infection. Bell et al. (1992) showed that three isotypes of IgG (IgGl, IgG2a, and IgG2c)

in rats were actively produced by B cells against this infection. Other groups have shown

drastic increases of IgA (Van Loveren et al., 1988; Brown et al., 1989), or high increases
of IgE (Wang et al., 1998; Negrao-Correa et al., 1996) against the same parasite. Based

on recent findings (Wang et al., 1998; Wang et al., 1999), it was shown that IgEproducing B cells produced the strongest response against the 9D4 antigen of Trichinella
spiralis. Therefore, IgE was used as a common Ab label for testing the dual Ab

expression on B cells in this experiment. Quantitative examination of dual Ab-bearing B
cells and single Ab-expressing B cells from the small intestine, spleen, mesenteric lymph

node, Peyer’s patch germinal centers, and Peyer’s patch non-germinal centers of

Sprague-Dawley rats are reported in this thesis. Among the different Ab isotypes tested
using a double-labeling immunofluorescence assay were IgA, IgM, IgGl, IgG2a, IgG2b,

or IgG2c, respectively, combined with the common IgE Ab. A separate

immunofluorescence assay was also carried out to quantify total B cell numbers within
the same tissues to examine the possibility that B cells in rats may be expressing multiple

Ab isotypes on the surface during Trichinella spiralis infection.

A significant increase in the expression of two Ab isotypes on the surface of B
cells over the controls and the single Ab-expressing B cells in the non-Peyer’s patch

region of the small intestine occurred as of day 3 post infection for all of the isotypes
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tested (Fig. 2-7). This shows that B cells are being activated to proliferate and produce

Ab in the small intestine very early after infection with Trichinella spiralis. Most B cells

become activated to undergo clonal proliferation through interactions with T helper cells,
and Wang et al. (1990) showed that intestinal T cells are actually activated as early as 12
hrs post infection with the same parasite. Therefore, this indicates that it takes less than 2
days for the intestinal T cells to activate B cells in the intestine. These B cells then

immediately start expressing many Ab isotypes on the surface and most likely are

secreting these Ab into the mucosal tissues. A very small population of B cells in the
controls of the intestinal villi was found (Fig. 2-7 and Fig. 33). As the infection was
prolonged, the B cells seemed to actively proliferate in this area at a rapid rate when
compared to other lymphoid tissues. The concentration of B cells per villus crypt unit of

the small intestine was higher than those found per field in all of the lymphoid tissues
studied (Fig. 2-31). This drastic kinetic augmentation shows that the B cells, which are

present in the villi of the small intestine, are actively proliferating to fight off the

infection even before the other surrounding lymphoid tissues are showing signs of B cell

activation. Therefore the nonlymphoid region of the small intestine does have an
enormous capability to mount an effective immune response against Trichinella spiralis

infection.
Similar effects on activation were seen in the lymphoid tissues as well, but it was
a somewhat delayed B cell proliferative response and also with less concentration of B
cells as was found in the non-lymphoid region of the small intestine. Within the nongerminal center region of the Peyer’s patches, there was a relatively low rate of
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proliferation with a significant increase only 7 days after infection (Fig. 20-25). Most of

the B cell proliferation in the Peyer’s patches occurred within the germinal center region.

This is believed to be the location where most of the B cell proliferation is normally
occurring, and therefore is likely the reason for the higher number of Ab-expressing B

cells in this area found in this study (Fig. 26-31). Within the germinal centers, a high
number of Ab-expressing B cells was identified, with variable significant rates of Ab-

expressing B cells first found from day 5 for IgAJgE-Debc to day 7 for the other Ab
isotypes (Fig. 26-31). The kinetics of dual Ab-expressing B cell proliferation in this

region was delayed somewhat compared to that of the small intestinal villi, but the total
number of B cells seemed to be comparable on the peak days of infection. The difference

was that germinal centers of the controls showed a relatively high number of Abexpressing B cells which was nearly six times greater than that found in the small
intestinal villi (Fig. 2-7 and Fig. 26-31). As infection proceeded the B cells were likely
shunted toward the villi of the small intestine from the germinal centers, as well as active
proliferation of the B cells within the villi which would account for the rapid

augmentation in these Ab-expressing B cells within this area.
MLN and the spleen were also delayed in the appearance of proliferation of dual

Ab-expressing B cells to Trichinella spiralis infection (Fig. 8-19). This delayed response

was expected because these tissues would be among the last to receive any signal of
infection within the small intestine. MLN is the lymphoid tissue that drains the lymph

derived from the Peyer’s patch and the small intestine, so the activated T cells and/or B
cells would have to migrate into this area before a local activation could occur. Since the
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initial activation of the Th cells and the dual Ab-expressing B cells is in the small
intestine, the B cells within the MLN would naturally show delayed response to this

intestinal infection until activated T cells and/or Ab-expressing B cells from the small
intestine are diverted into this region. The spleen is a major organ of the systemic

lymphatic system, and therefore activated Th cells and/or the dual Ab-expressing B cells
from the local mucosal region of the small intestine would have to become systemic and

spread before activation could occur within this area. Another possible reason for the

delayed response within theses two lymphoid tissues could be related to the reproduction
and systemic migration of Trichinella spiralis new bom larvae (NBL). As the larvae
disseminate out of the small intestine to the various tissues of the body, activation of new

B cells would occur. Similarly the intestinal parasite could also secrete Ag which could
be drained into the systemic circulation. Such Ag could in turn stimulate the MLN,

spleen, and other lymphoid tissues, and then lead to a generation of a humoral immune
response.
Within the different tissues examined throughout the duration of the experiment,

it was found that B cells expressed all of the different Ab isotypes. In the villi of the
small intestine (Fig. 2-7), spleen (Fig. 8-13), MLN (Fig. 14-19), and non-germinal center

regions of the Peyer’s patches (Fig. 20-25), no significant quantitative differences
between the numbers of B cells expressing different dual Ab-isotypes were revealed

during each day after infection. Therefore these results suggest that these B cells are

being activated to synthesize all of the different Ab isotypes to fight off the Trichinella
spiralis infection in both the lymphoid and the nonlymphoid tissues. This makes sense
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because in theory, the greater the variety of a response to a specific Ag, the greater the

chance of destroying the Ag before extensive damage occurs. So the more variety of Ab
that is produced against Trichinella spiralis, the more effective the immune response
should be. In the germinal center regions of the Peyer’s patches all of the different

isotypes were also expressed by B cells, but different isotypes were detected at different
times throughout the infection (Fig. 26-31). In the controls there was a higher number of
IgA- and IgM-expressing B cells, but as the infection took place and proceeded through

time, similar quantities of the Ab-expressing B cells were found as compared to that of

other Ab-expressing B cells (Fig. 26-27). This shows that under normal conditions, the

Peyer’s patch germinal centers produce B cells that mostly express IgA and IgM, which
confirms many previous studies (Van Loveren et al., 1988; Brandtzaeg, 1996; Ehrhardt et

al., 1996). However, once an infection of Trichinella spiralis occurs, B cells are quickly
stimulated to lead to various Ab isotypes being expressed. Although IgE-expression was
not measured alone in the tissues of this experiment, it was found in high amounts on the
dual Ab-expressing B cells that would show that it was also being actively produced by B

cells against this parasite (Fig. 2-31). Most mucosal B cell research revolves around IgA
production within the Peyer’s patches of the small intestine (Kawanishi et al., 1983;

Spencer et al., 1986; Homquist et al., 1995), but in this experiment it was shown that

there were B cells expressing all of the different isotypes after infection with Trichinella

spiralis. It has also been shown that IgA is not the only isotype produced, and that IgA

does not even appear to be the major isotype produced against this infection in any of the

four tissues tested. As would be expected from a parasitic infection, and from previous
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studies (Wang et al., 1998; Negrao-Correa et al., 1996), IgE would appear to be the major

single Ab produced by B cells against Trichinella spiralis. In this experiment though, all
of the other Ab isotypes are also expressed in similar high quantities to that of IgE as

well. Therefore no single Ab isotype produced by B cells dominated any other isotype
against this infection.

The various Ab isotypes expressed by B cells were demonstrated through the use

of double labeling of the B cells for two Ab isotypes. In the small intestine significant

increase of dual Ab-expression of B cells first occurred on day 3 after infection with
Trichinella spiralis, and the peak days were on days 7 and 10 (Fig. 2-7). Based on the

amount of dual Ab-expressing B cells that were counted per villus on average (between
21.26±4.71 and 29.01±3.87) for each of the dual Ab-labeled combinations, it would

appear that each villus would become overwhelmed with B cells alone and not leave any
space for other cells of the immune system to function. For this reason a total B cell
count, using 0X33 monoclonal Ab to label CD45RA found only on B cells in rats, was

taken to determine the quantities of B cells within each villus. For the controls and the
first 3 days post infection, no differences were found between the total number of B cells
and the total number of dual Ab-expressing B cells for each of the combinations. When

calculating and adding all of the different combinations of dual Ab-expressing B cells for
each of the peak days post infection (day 7 and day 10) (Fig. 2-7), the average number of
dual Ab-expressing B cells per VCU considerably outnumbered that of the expected total

B cell numbers from the 0X33 labeled cells (Fig. 33). The total dual Ab-expressing B
cells on day 7 after infection was more than 7 times that of the detected total number of
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OX33-labeled B cells (Fig. 33). Dual Ab-expressing B cells on day 10 post infection
when combined was over 5 times that of the actual total number of B cells revealed

through 0X33 labeling (Fig. 2-7 and Fig. 33). This indicates that these B cells are not

only expressing two Ab isotypes on the surface as was shown, but are most likely

expressing more than just the two isotypes of Ab during Trichinella spiralis infection.
This phenomenon could lead to a greater variation in response to the Trichinella spiralis

Ag, and a much more rapid expulsion of the parasite from the rat intestine. As of day 15
after infection, the total number of dual Ab-expressing B cells combined in the small
intestine on average was < 3 times over that of the 0X33 labeled B cells. This decreasing

tendency of possible multiple Ab-expressing B cells in the non-Peyer’s patch regions of

the small intestine from the peak day 7 through day 15 is most likely due to an increase in

B cells that have been switched to single Ab-expressing B cells again. Another reason
for this reduced number of possible multiple Ab-producing B cells could be from the
production of memory B cells as the infection is prolonged.

The same kinetics of appearance of B cells seen in the small intestine was also
present in the lymphoid tissues, with the B cells being shown to express dual Ab isotypes

on the surface. When comparing the dual Ab-labeled B cells of the various lymphoid
tissues to the 0X3 3-labeled B cells in these tissues, our data suggests more than two
isotypes being expressed on the surface of B cells. This not only confirms what was

found in the nonlymphoid region of the small intestine, but also strengthens the theory

proposed above that these dual Ab-expressing B cells are synthesizing more than just two
isotypes at any particular point in time. The difference of 0X3 3+ B cells in the lymphoid
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tissues was similar to that found in the proliferation of the Ab-expressing B cells, which
mustered delayed response to the Trichinella spiralis infection compared to that of the

nonlymphoid region of the small intestine. No significant increase in the number of dual
Ab-expressing B cells was noticed in the spleen or in the mesenteric lymph node until

days 10 and 15 after infection (Fig. 8-19). The number of dual Ab-expressing B cells in

the spleen peaked on day 10 which was greater than 6 times higher than the total 0X33-

labeled B cells, and the ratio dropped to less than 3 times on day 15 (Fig. 8-13). In the

MLN, the number of dual Ab-expressing B cells was only about 3 times higher on day 10
where as it was less than twice the amount of the 0X33 labeled B cells on day 15 (Fig.
14-19). This demonstrates that the B cells in the MLN and spleen are possibly expressing

more than two Ab isotypes on the peak days of B cell proliferation, but during most of
the infection they are expressing only up to two isotypes. This was remarkably different

from what was found in the small intestine. It is most probable that a major portion of
the activated dual Ab-expressing B cells in the spleen and MLN result from differentiated

B cells or from new dual Ab-expressing B cells that arrived from the small intestine.
These activated B cells could have also been a result from NBL that migrated to these

tissues, or were activated by parasitic Ag that arrived in these tissues during the process
of infection. If activated T cells and/or B cells from the small intestine were drained into

one of the lymphoid tissues, then proliferation could result within these areas as well.
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Dual labeled B cells in the non-germinal center region of the Peyer’s patch though

present, remained relatively low throughout the entire experiment (Fig. 20-25) so when

comparing these cells to the 0X33 labeled cells (Fig. 36) no multiple expression could be
determined. To the contrary, the germinal centers of the Peyer’s patch demonstrated

much more similar kinetics of the numbers of dual Ab-expressing B cells to that of the
villi in the small intestine. On day 7 the compiled count of dual Ab-bearing B cells was

greater than 2 times that of the total B cells quantified using the 0X33 labeled cells.

Within the PP-GC however, there was a steady increase of double labeled B cells through
day 10, which was just less than 5 times greater than the 0X33 labeled cells, and day 15
of greater than 5 times that of the 0X33 labeled B cells (Fig. 26-31 and Fig. 37). These
results show that the B cells in the PP-GC are also conceivably producing multiple Ab
isotypes by day 7 post infection. The number of dual Ab-expressing B cells in the PP-

GC though is less than that found in the non-Peyer’s patch region of the small intestine
and the dynamics of appearance of these B cells is also more delayed. So the duallabeled B cells in the small intestine are likely activated to proliferate within this
normally nonlymphoid region without the need from B cells in the Peyer’s patches

migrating into this region. Based on the results, these intestinal B cells are possibly

producing more Ab than just the two tested for in the lamina propria of the small

intestine.

'<

Most studies involving B cells research focus on B cells producing one Ab

isotype at a time only. There have been only few studies involving dual-labeled B cells

(Chen et al., 1986; Karttunen et al., 1991; Goodman et al., 1997), and no studies to date
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on the possible expression of multiple Ab isotypes by B cells. In this study, activated B
cells expressing dual Ab isotypes on the surface were stimulated by Trichinella spiralis

and were identified and quantified using the double-labeling immunofluorescence assay.

Based on the results presented here, it appears that these B cells most likely express

multiple isotypes. This strongly suggests that in these intestinal B cells, there is

tremendous RNA splicing activities following Trichinella spiralis antigenic stimulation
and activation of T helper cells. DNA gene rearrangement and recombination events may

also occur, but at a much lower rate as indicated by the extreme low level of single

isotype expressing B cells in these tissues. Other studies using different cell lines in vitro
have also suggested RNA splicing in mouse (Shimizu et al., 1991; Wu et al., 1991) and

human cells (Akahori et al., 1990; Caldwell et al., 1991; Nolan-Willard et al., 1992), but

future research is needed to determine if RNA splicing mechanisms also occur in rats.
Further research is also needed in this area to determine if this mechanism occurs in vivo,

and allows for B cells to produce more than two Ab isotypes during Trichinella spiralis

infection.
A possible problem that may have skewed some of the results of this research is

that of Ab binding to FcR of cells involved in the nonspecific immune responses.

Neutrophils, eosinophils, basophils, and M<j) were not tested for in this study at any point
during infection. B cells could have secreted out Ab which in turn bind to the FcR of
these cells. Ab probes that were used would then bind to the Fc region of the Ab

connected to the cells FcR and fluoresce, thereby giving a positive signal as being an Abexpressing B cell. This occurrence though was conceivably extremely minimal, because
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most nonspecific cells in rats have only been shown to express one type of FcR on the
surface, or were not consistent with the dual-Ab tested for. Neutrophils have FcR for IgG
and IgA (Isashi et al., 1995), but has not been found to bind IgE. Eosinophils and

basophils express FcR only for IgE (Alber et al., 1992), and M<j> only subtypes of IgG
(Ravetch, 1991). These cells would then only allow for an increase in the number of

single Ab-expressing cells, which remained very low in all of the tissues throughout the
experiment. The only exception found to date is that of mast cells that have the
capability of expressing FcR for IgE and IgG2a in rats (Alber et al., 1992). In other
experimental systems such as mouse and human, FcR specific to more Ab isotypes have

been shown (Unkeless et al., 1988; Takizawa et al., 1992; Ravetch, 1991). Studies with
multiple fluorescent markers, or using the fluorescent activated cell sorter analysis to

count the various B cells would make the procedures much more accurate and also
involve much less time. Currently, the state-of-the-art technology could allow for the

detection of three fluorescent markers simultaneously, but in this experiment access was

limited to only two different markers. This would allow for more extensive studies and
more conclusive results as to the theory of multiple Ab production by B cells. Future
experiments to determine the specific gene rearrangement of the Ab within these various
B cells, and to determine if RNA splicing of the new Ab is the mode of synthesis of Ab

could also aid in the better understanding of multiple expression of B cells.
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